{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T16:24:20Z","timestamp":1795278260765,"version":"4.10.3"},"reference-count":544,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Copper, an essential micronutrient, plays significant roles in numerous biological functions. Recent studies have identified imbalances in copper homeostasis across various cancers, along with the emergence of cuproptosis, a novel copper-dependent form of cell death that is crucial for tumor suppression and therapeutic resistance. As a result, manipulating copper levels has garnered increasing interest as an innovative approach to cancer therapy. In this review, we first delineate copper homeostasis at both cellular and systemic levels, clarifying copper\u2019s protumorigenic and antitumorigenic functions in cancer. We then outline the key milestones and molecular mechanisms of cuproptosis, including both mitochondria-dependent and independent pathways. Next, we explore the roles of cuproptosis in cancer biology, as well as the interactions mediated by cuproptosis between cancer cells and the immune system. We also summarize emerging therapeutic opportunities targeting copper and discuss the clinical associations of cuproptosis-related genes. Finally, we examine potential biomarkers for cuproptosis and put forward the existing challenges and future prospects for leveraging cuproptosis in cancer therapy. Overall, this review enhances our understanding of the molecular mechanisms and therapeutic landscape of copper and cuproptosis in cancer, highlighting the potential of copper- or cuproptosis-based therapies for cancer treatment.<\/jats:p>","DOI":"10.1038\/s41392-025-02192-0","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:02:25Z","timestamp":1746730945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":216,"title":["The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Ziyu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Dian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-636X","authenticated-orcid":false,"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-9727","authenticated-orcid":false,"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2192_CR1","doi-asserted-by":"publisher","first-page":"114791","DOI":"10.1016\/j.biopha.2023.114791","volume":"163","author":"D Guan","year":"2023","unstructured":"Guan, D. et al. Copper in cancer: from pathogenesis to therapy. Biomed. Pharmacother. 163, 114791 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2192_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1126\/science.349.6244.129","volume":"349","author":"K Garber","year":"2015","unstructured":"Garber, K. Cancer\u2019s copper connections. Science 349, 129 (2015).","journal-title":"Science"},{"key":"2192_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1724","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Copper in colorectal cancer: from copper-related mechanisms to clinical cancer therapies. Clin. Transl. Med. 14, e1724 (2024).","journal-title":"Clin. Transl. Med."},{"key":"2192_CR4","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","volume":"21","author":"RA Festa","year":"2011","unstructured":"Festa, R. A. & Thiele, D. J. Copper: an essential metal in biology. Curr. Biol. 21, R877\u2013R883 (2011).","journal-title":"Curr. Biol."},{"key":"2192_CR5","doi-asserted-by":"crossref","unstructured":"Linder, M. C. Copper homeostasis in mammals, with emphasis on secretion and excretion. a review. Int. J. Mol. Sci. 21, (2020).","DOI":"10.3390\/ijms21144932"},{"key":"2192_CR6","doi-asserted-by":"publisher","first-page":"216157","DOI":"10.1016\/j.canlet.2023.216157","volume":"561","author":"X Wang","year":"2023","unstructured":"Wang, X., Zhou, M., Liu, Y. & Si, Z. Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies. Cancer Lett. 561, 216157 (2023).","journal-title":"Cancer Lett."},{"key":"2192_CR7","doi-asserted-by":"publisher","first-page":"122223","DOI":"10.1016\/j.lfs.2023.122223","volume":"334","author":"Z Tian","year":"2023","unstructured":"Tian, Z., Jiang, S., Zhou, J. & Zhang, W. Copper homeostasis and cuproptosis in mitochondria. Life Sci. 334, 122223 (2023).","journal-title":"Life Sci."},{"key":"2192_CR8","doi-asserted-by":"crossref","unstructured":"An, Y. et al. The role of copper homeostasis in brain disease. Int. J. Mol. Sci. 23, (2022).","DOI":"10.3390\/ijms232213850"},{"key":"2192_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct. Target Ther. 7, 378 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"2192_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nchembio.72","volume":"4","author":"BE Kim","year":"2008","unstructured":"Kim, B. E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4, 176\u2013185 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"2192_CR11","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/iub.2341","volume":"72","author":"Y Li","year":"2020","unstructured":"Li, Y. Copper homeostasis: emerging target for cancer treatment. IUBMB Life 72, 1900\u20131908 (2020).","journal-title":"IUBMB Life"},{"key":"2192_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.nu.15.070195.001453","volume":"15","author":"CD Vulpe","year":"1995","unstructured":"Vulpe, C. D. & Packman, S. Cellular copper transport. Annu. Rev. Nutr. 15, 293\u2013322 (1995).","journal-title":"Annu. Rev. Nutr."},{"key":"2192_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.nutr.20.1.291","volume":"20","author":"ED Harris","year":"2000","unstructured":"Harris, E. D. Cellular copper transport and metabolism. Annu. Rev. Nutr. 20, 291\u2013310 (2000).","journal-title":"Annu. Rev. Nutr."},{"key":"2192_CR14","doi-asserted-by":"crossref","unstructured":"Lutsenko, S. Dynamic and cell-specific transport networks for intracellular copper ions. J. Cell Sci. 134, (2021).","DOI":"10.1242\/jcs.240523"},{"key":"2192_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216348","volume":"571","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Copper in hepatocellular carcinoma: a double-edged sword with therapeutic potentials. Cancer Lett. 571, 216348 (2023).","journal-title":"Cancer Lett."},{"key":"2192_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue, Q. et al. Copper metabolism in cell death and autophagy. Autophagy 19, 2175\u20132195 (2023).","journal-title":"Autophagy"},{"key":"2192_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat. Rev. Cancer 22, 102\u2013113 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2192_CR18","doi-asserted-by":"publisher","first-page":"1203447","DOI":"10.3389\/fphar.2023.1203447","volume":"14","author":"R Kong","year":"2023","unstructured":"Kong, R. & Sun, G. Targeting copper metabolism: a promising strategy for cancer treatment. Front. Pharm. 14, 1203447 (2023).","journal-title":"Front. Pharm."},{"key":"2192_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41556-021-00822-7","volume":"24","author":"A Das","year":"2022","unstructured":"Das, A. et al. Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nat. Cell Biol. 24, 35\u201350 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2192_CR20","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","volume":"80","author":"F Voli","year":"2020","unstructured":"Voli, F. et al. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion. Cancer Res. 80, 4129\u20134144 (2020).","journal-title":"Cancer Res."},{"key":"2192_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153582","volume":"494","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. Upregulation of postsynaptic cAMP\/PKA\/CREB signaling alleviates copper(II)-induced oxidative stress and pyroptosis in MN9D cells. Toxicology 494, 153582 (2023).","journal-title":"Toxicology"},{"key":"2192_CR22","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue, Q. et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19, 1982\u20131996 (2023).","journal-title":"Autophagy"},{"key":"2192_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/nnm-2021-0374","volume":"17","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine 17, 303\u2013324 (2022).","journal-title":"Nanomedicine"},{"key":"2192_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/ijbs.84733","volume":"20","author":"KH Tsui","year":"2024","unstructured":"Tsui, K. H. et al. The cross-communication of cuproptosis and regulated cell death in human pathophysiology. Int. J. Biol. Sci. 20, 218\u2013230 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"2192_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111060","volume":"396","author":"D Zhao","year":"2024","unstructured":"Zhao, D. et al. Copper exposure induces inflammation and PANoptosis through the TLR4\/NF-\u03baB signaling pathway, leading to testicular damage and impaired spermatogenesis in Wilson disease. Chem. Biol. Interact. 396, 111060 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"2192_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"2192_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1074\/jbc.R800055200","volume":"284","author":"ML Turski","year":"2009","unstructured":"Turski, M. L. & Thiele, D. J. New roles for copper metabolism in cell proliferation, signaling, and disease. J. Biol. Chem. 284, 717\u2013721 (2009).","journal-title":"J. Biol. Chem."},{"key":"2192_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biocel.2018.07.001","volume":"102","author":"H Zischka","year":"2018","unstructured":"Zischka, H. & Einer, C. Mitochondrial copper homeostasis and its derailment in Wilson disease. Int. J. Biochem. Cell Biol. 102, 71\u201375 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2192_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann, O., Weiss, K. H. & Kaler, S. G. Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol. 14, 103\u2013113 (2015).","journal-title":"Lancet Neurol."},{"key":"2192_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00018-007-7439-6","volume":"65","author":"I Bertini","year":"2008","unstructured":"Bertini, I. & Rosato, A. Menkes disease. Cell Mol. Life Sci. 65, 89\u201391 (2008).","journal-title":"Cell Mol. Life Sci."},{"key":"2192_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.aaz8899","volume":"368","author":"LM Guthrie","year":"2020","unstructured":"Guthrie, L. M. et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science 368, 620\u2013625 (2020).","journal-title":"Science"},{"key":"2192_CR32","doi-asserted-by":"crossref","unstructured":"Gromadzka, G., Tarnacka, B., Flaga, A. & Adamczyk, A. Copper dyshomeostasis in neurodegenerative diseases-therapeutic implications. Int. J. Mol. Sci. 21 (2020).","DOI":"10.3390\/ijms21239259"},{"key":"2192_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","volume":"44","author":"L Yang","year":"2023","unstructured":"Yang, L., Yang, P., Lip, G. Y. H. & Ren, J. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharm. Sci. 44, 573\u2013585 (2023).","journal-title":"Trends Pharm. Sci."},{"key":"2192_CR34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41440-024-01636-4","volume":"47","author":"R Parsanathan","year":"2024","unstructured":"Parsanathan, R. Copper\u2019s dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases. Hypertens. Res. 47, 1440\u20131442 (2024).","journal-title":"Hypertens. Res."},{"key":"2192_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2021.111634","volume":"226","author":"DA da Silva","year":"2022","unstructured":"da Silva, D. A. et al. Copper in tumors and the use of copper-based compounds in cancer treatment. J. Inorg. Biochem. 226, 111634 (2022).","journal-title":"J. Inorg. Biochem."},{"key":"2192_CR36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","volume":"472","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflug. Arch. 472, 1415\u20131429 (2020).","journal-title":"Pflug. Arch."},{"key":"2192_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.36290\/csf.2018.021","volume":"67","author":"M Vetch\u00fd","year":"2018","unstructured":"Vetch\u00fd, M. Biological role of copper as an essential trace element in the human organism. Ceska Slov. Farm 67, 143\u2013153 (2018).","journal-title":"Ceska Slov. Farm"},{"key":"2192_CR38","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","volume":"31","author":"T Tsang","year":"2021","unstructured":"Tsang, T., Davis, C. I. & Brady, D. C. Copper biology. Curr. Biol. 31, R421\u2013r427 (2021).","journal-title":"Curr. Biol."},{"key":"2192_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10534-020-00264-y","volume":"34","author":"H Shi","year":"2021","unstructured":"Shi, H. et al. Copper metabolism in Saccharomyces cerevisiae: an update. Biometals 34, 3\u201314 (2021).","journal-title":"Biometals"},{"key":"2192_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1753-4887.2001.tb07017.x","volume":"59","author":"ED Harris","year":"2001","unstructured":"Harris, E. D. Copper homeostasis: the role of cellular transporters. Nutr. Rev. 59, 281\u2013285 (2001).","journal-title":"Nutr. Rev."},{"key":"2192_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/10937404.2010.538657","volume":"13","author":"A Chambers","year":"2010","unstructured":"Chambers, A. et al. An exposure-response curve for copper excess and deficiency. J. Toxicol. Environ. Health B Crit. Rev. 13, 546\u2013578 (2010).","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"2192_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1469-8137.2009.02846.x","volume":"182","author":"JL Burkhead","year":"2009","unstructured":"Burkhead, J. L. et al. Copper homeostasis. N. Phytol. 182, 799\u2013816 (2009).","journal-title":"N. Phytol."},{"key":"2192_CR43","doi-asserted-by":"publisher","first-page":"e1010617","DOI":"10.1371\/journal.ppat.1010617","volume":"18","author":"F Focarelli","year":"2022","unstructured":"Focarelli, F., Giachino, A. & Waldron, K. J. Copper microenvironments in the human body define patterns of copper adaptation in pathogenic bacteria. PLoS Pathog. 18, e1010617 (2022).","journal-title":"PLoS Pathog."},{"key":"2192_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05639-w","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis. 14, 105 (2023).","journal-title":"Cell Death Dis."},{"key":"2192_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtemb.2016.02.006","volume":"35","author":"M Bost","year":"2016","unstructured":"Bost, M. et al. Dietary copper and human health: current evidence and unresolved issues. J. Trace Elem. Med. Biol. 35, 107\u2013115 (2016).","journal-title":"J. Trace Elem. Med. Biol."},{"key":"2192_CR46","unstructured":"Institute of Medicine Panel on, M. in Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved, 2001)."},{"key":"2192_CR47","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/jn\/109.11.1979","volume":"109","author":"KE Mason","year":"1979","unstructured":"Mason, K. E. A conspectus of research on copper metabolism and requirements of man. J. Nutr. 109, 1979\u20132066 (1979).","journal-title":"J. Nutr."},{"key":"2192_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202736119","volume":"119","author":"AT Pezacki","year":"2022","unstructured":"Pezacki, A. T. et al. Oxidation state-specific fluorescent copper sensors reveal oncogene-driven redox changes that regulate labile copper(II) pools. Proc. Natl. Acad. Sci. USA 119, e2202736119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tem.2022.11.001","volume":"34","author":"NM Garza","year":"2023","unstructured":"Garza, N. M. et al. Mitochondrial copper in human genetic disorders. Trends Endocrinol. Metab. 34, 21\u201333 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"2192_CR50","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.biocel.2013.01.018","volume":"45","author":"NK Wee","year":"2013","unstructured":"Wee, N. K., Weinstein, D. C., Fraser, S. T. & Assinder, S. J. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int. J. Biochem. Cell Biol. 45, 960\u2013963 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2192_CR51","doi-asserted-by":"publisher","first-page":"54221","DOI":"10.1074\/jbc.M411669200","volume":"279","author":"EM Rees","year":"2004","unstructured":"Rees, E. M., Lee, J. & Thiele, D. J. Mobilization of intracellular copper stores by the ctr2 vacuolar copper transporter. J. Biol. Chem. 279, 54221\u201354229 (2004).","journal-title":"J. Biol. Chem."},{"key":"2192_CR52","doi-asserted-by":"publisher","first-page":"C1525","DOI":"10.1152\/ajpcell.00480.2002","volume":"284","author":"M Arredondo","year":"2003","unstructured":"Arredondo, M., Mu\u00f1oz, P., Mura, C. V. & N\u00f9\u00f1ez, M. T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 284, C1525\u2013C1530 (2003).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2192_CR53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang, D., Kroemer, G. & Kang, R. Targeting cuproplasia and cuproptosis in cancer. Nat. Rev. Clin. Oncol. 21, 370\u2013388 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2192_CR54","doi-asserted-by":"publisher","first-page":"846s","DOI":"10.1093\/ajcn\/88.3.846S","volume":"88","author":"B L\u00f6nnerdal","year":"2008","unstructured":"L\u00f6nnerdal, B. Intestinal regulation of copper homeostasis: a developmental perspective. Am. J. Clin. Nutr. 88, 846s\u2013850s (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"2192_CR55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10534-008-9139-6","volume":"21","author":"A Cabrera","year":"2008","unstructured":"Cabrera, A. et al. Copper binding components of blood plasma and organs, and their responses to influx of large doses of (65)Cu, in the mouse. Biometals 21, 525\u2013543 (2008).","journal-title":"Biometals"},{"key":"2192_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62560-4","volume":"10","author":"T Kirsipuu","year":"2020","unstructured":"Kirsipuu, T. et al. Copper(II)-binding equilibria in human blood. Sci. Rep. 10, 5686 (2020).","journal-title":"Sci. Rep."},{"key":"2192_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie, J., Yang, Y., Gao, Y. & He, J. Cuproptosis: mechanisms and links with cancers. Mol. Cancer 22, 46 (2023).","journal-title":"Mol. Cancer"},{"key":"2192_CR58","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/iub.1618","volume":"69","author":"J Calvo","year":"2017","unstructured":"Calvo, J., Jung, H. & Meloni, G. Copper metallothioneins. IUBMB Life 69, 236\u2013245 (2017).","journal-title":"IUBMB Life"},{"key":"2192_CR59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.biocel.2009.11.007","volume":"42","author":"S La Fontaine","year":"2010","unstructured":"La Fontaine, S., Ackland, M. L. & Mercer, J. F. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int. J. Biochem. Cell Biol. 42, 206\u2013209 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2192_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.abb.2007.04.021","volume":"463","author":"S La Fontaine","year":"2007","unstructured":"La Fontaine, S. & Mercer, J. F. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys. 463, 149\u2013167 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"2192_CR61","doi-asserted-by":"crossref","unstructured":"Rondanelli, M. et al. Copper as dietary supplement for bone metabolism: a review. Nutrients. 13, (2021).","DOI":"10.3390\/nu13072246"},{"key":"2192_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.mib.2004.02.004","volume":"7","author":"EM Rees","year":"2004","unstructured":"Rees, E. M. & Thiele, D. J. From aging to virulence: forging connections through the study of copper homeostasis in eukaryotic microorganisms. Curr. Opin. Microbiol. 7, 175\u2013184 (2004).","journal-title":"Curr. Opin. Microbiol."},{"key":"2192_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bpj.2015.11.025","volume":"110","author":"JH Kaplan","year":"2016","unstructured":"Kaplan, J. H. & Maryon, E. B. How mammalian cells acquire copper: an essential but potentially toxic metal. Biophys. J. 110, 7\u201313 (2016).","journal-title":"Biophys. J."},{"key":"2192_CR64","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, C. & Mart\u00ednez-Gonz\u00e1lez, J. The role of lysyl oxidase enzymes in cardiac function and remodeling. Cells. 8, (2019).","DOI":"10.3390\/cells8121483"},{"key":"2192_CR65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jnr.23143","volume":"91","author":"ED Gaier","year":"2013","unstructured":"Gaier, E. D., Eipper, B. A. & Mains, R. E. Copper signaling in the mammalian nervous system: synaptic effects. J. Neurosci. Res 91, 2\u201319 (2013).","journal-title":"J. Neurosci. Res"},{"key":"2192_CR66","first-page":"214","volume":"4","author":"PJ Aggett","year":"1999","unstructured":"Aggett, P. J. An overview of the metabolism of copper. Eur. J. Med. Res. 4, 214\u2013216 (1999).","journal-title":"Eur. J. Med. Res."},{"key":"2192_CR67","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/ajcn\/49.5.870","volume":"49","author":"JR Turnlund","year":"1989","unstructured":"Turnlund, J. R., Keyes, W. R., Anderson, H. L. & Acord, L. L. Copper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65Cu. Am. J. Clin. Nutr. 49, 870\u2013878 (1989).","journal-title":"Am. J. Clin. Nutr."},{"key":"2192_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/acs.analchem.6b04631","volume":"89","author":"CM Ackerman","year":"2017","unstructured":"Ackerman, C. M., Lee, S. & Chang, C. J. Analytical methods for imaging metals in biology: from transition metal metabolism to transition metal signaling. Anal. Chem. 89, 22\u201341 (2017).","journal-title":"Anal. Chem."},{"key":"2192_CR69","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.040461197","volume":"97","author":"PC Wong","year":"2000","unstructured":"Wong, P. C. et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu\/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 97, 2886\u20132891 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR70","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-biochem-030409-143539","volume":"79","author":"NJ Robinson","year":"2010","unstructured":"Robinson, N. J. & Winge, D. R. Copper metallochaperones. Annu. Rev. Biochem 79, 537\u2013562 (2010).","journal-title":"Annu. Rev. Biochem"},{"key":"2192_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.freeradbiomed.2009.05.018","volume":"47","author":"L Miao","year":"2009","unstructured":"Miao, L. & St Clair, D. K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 47, 344\u2013356 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR72","doi-asserted-by":"publisher","first-page":"38084","DOI":"10.1074\/jbc.M105296200","volume":"276","author":"LA Sturtz","year":"2001","unstructured":"Sturtz, L. A. et al. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 276, 38084\u201338089 (2001).","journal-title":"J. Biol. Chem."},{"key":"2192_CR73","doi-asserted-by":"publisher","first-page":"38388","DOI":"10.1074\/jbc.M105395200","volume":"276","author":"A Okado-Matsumoto","year":"2001","unstructured":"Okado-Matsumoto, A. & Fridovich, I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J. Biol. Chem. 276, 38388\u201338393 (2001).","journal-title":"J. Biol. Chem."},{"key":"2192_CR74","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/sj.emboj.7600276","volume":"23","author":"Y Furukawa","year":"2004","unstructured":"Furukawa, Y., Torres, A. S. & O\u2019Halloran, T. V. Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. Embo J. 23, 2872\u20132881 (2004).","journal-title":"Embo J."},{"key":"2192_CR75","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1039\/c9mt00081j","volume":"11","author":"D Lorenzo-Guti\u00e9rrez","year":"2019","unstructured":"Lorenzo-Guti\u00e9rrez, D. et al. Role of the Fusarium oxysporum metallothionein Mt1 in resistance to metal toxicity and virulence. Metallomics 11, 1230\u20131240 (2019).","journal-title":"Metallomics"},{"key":"2192_CR76","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/jn\/120.11.1370","volume":"120","author":"HJ McArdle","year":"1990","unstructured":"McArdle, H. J., Mercer, J. F., Sargeson, A. M. & Danks, D. M. Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes. J. Nutr. 120, 1370\u20131375 (1990).","journal-title":"J. Nutr."},{"key":"2192_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0092-8674(88)90229-2","volume":"55","author":"P F\u00fcrst","year":"1988","unstructured":"F\u00fcrst, P., Hu, S., Hackett, R. & Hamer, D. Copper activates metallothionein gene transcription by altering the conformation of a specific DNA binding protein. Cell 55, 705\u2013717 (1988).","journal-title":"Cell"},{"key":"2192_CR78","doi-asserted-by":"publisher","first-page":"118867","DOI":"10.1016\/j.bbamcr.2020.118867","volume":"1868","author":"PA Cobine","year":"2021","unstructured":"Cobine, P. A., Moore, S. A. & Leary, S. C. Getting out what you put in: copper in mitochondria and its impacts on human disease. Biochim. Biophys. Acta Mol. Cell Res. 1868, 118867 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"2192_CR79","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1039\/C7MT00221A","volume":"9","author":"ZN Baker","year":"2017","unstructured":"Baker, Z. N., Cobine, P. A. & Leary, S. C. The mitochondrion: a central architect of copper homeostasis. Metallomics 9, 1501\u20131512 (2017).","journal-title":"Metallomics"},{"key":"2192_CR80","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist. Updat. 72, 101018 (2024).","journal-title":"Drug Resist. Updat."},{"key":"2192_CR81","doi-asserted-by":"publisher","first-page":"148156","DOI":"10.1016\/j.gene.2024.148156","volume":"902","author":"L Li","year":"2024","unstructured":"Li, L. et al. Cuproptosis\/OXPHOS tendency prediction of prognosis and immune microenvironment of esophageal squamous cell carcinoma: bioinformatics analysis and experimental validation. Gene 902, 148156 (2024).","journal-title":"Gene"},{"key":"2192_CR82","doi-asserted-by":"publisher","first-page":"15304","DOI":"10.1074\/jbc.M115.645069","volume":"290","author":"M Chojnacka","year":"2015","unstructured":"Chojnacka, M. et al. Cox17 protein is an auxiliary factor involved in the control of the mitochondrial contact site and cristae organizing system. J. Biol. Chem. 290, 15304\u201315312 (2015).","journal-title":"J. Biol. Chem."},{"key":"2192_CR83","doi-asserted-by":"publisher","first-page":"35334","DOI":"10.1074\/jbc.M404747200","volume":"279","author":"YC Horng","year":"2004","unstructured":"Horng, Y. C. et al. Specific copper transfer from the Cox17 metallochaperone to both Sco1 and Cox11 in the assembly of yeast cytochrome C oxidase. J. Biol. Chem. 279, 35334\u201335340 (2004).","journal-title":"J. Biol. Chem."},{"key":"2192_CR84","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1128\/MCB.22.21.7614-7621.2002","volume":"22","author":"Y Takahashi","year":"2002","unstructured":"Takahashi, Y. et al. Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development. Mol. Cell Biol. 22, 7614\u20137621 (2002).","journal-title":"Mol. Cell Biol."},{"key":"2192_CR85","doi-asserted-by":"crossref","unstructured":"Li, J. & Wang, Y. Golgi metal ion homeostasis in human health and diseases. Cells. 11, (2022).","DOI":"10.3390\/cells11020289"},{"key":"2192_CR86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1523\/JNEUROSCI.1284-20.2020","volume":"41","author":"C Hartwig","year":"2021","unstructured":"Hartwig, C. et al. Golgi-dependent copper homeostasis sustains synaptic development and mitochondrial content. J. Neurosci. 41, 215\u2013233 (2021).","journal-title":"J. Neurosci."},{"key":"2192_CR87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10753-011-9302-z","volume":"35","author":"HW Kim","year":"2012","unstructured":"Kim, H. W. et al. Human macrophage ATP7A is localized in the trans-Golgi apparatus, controls intracellular copper levels, and mediates macrophage responses to dermal wounds. Inflammation 35, 167\u2013175 (2012).","journal-title":"Inflammation"},{"key":"2192_CR88","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biophys.093008.131331","volume":"40","author":"MG Palmgren","year":"2011","unstructured":"Palmgren, M. G. & Nissen, P. P-type ATPases. Annu Rev. Biophys. 40, 243\u2013266 (2011).","journal-title":"Annu Rev. Biophys."},{"key":"2192_CR89","doi-asserted-by":"publisher","first-page":"36041","DOI":"10.1074\/jbc.M112.370403","volume":"287","author":"NM Hasan","year":"2012","unstructured":"Hasan, N. M. et al. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network. J. Biol. Chem. 287, 36041\u201336050 (2012).","journal-title":"J. Biol. Chem."},{"key":"2192_CR90","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1002\/j.1460-2075.1996.tb00997.x","volume":"15","author":"MJ Petris","year":"1996","unstructured":"Petris, M. J. et al. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 15, 6084\u20136095 (1996).","journal-title":"EMBO J."},{"key":"2192_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00418-013-1123-8","volume":"140","author":"R Polishchuk","year":"2013","unstructured":"Polishchuk, R. & Lutsenko, S. Golgi in copper homeostasis: a view from the membrane trafficking field. Histochem. Cell Biol. 140, 285\u2013295 (2013).","journal-title":"Histochem. Cell Biol."},{"key":"2192_CR92","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/hmg\/9.19.2845","volume":"9","author":"MJ Petris","year":"2000","unstructured":"Petris, M. J., Strausak, D. & Mercer, J. F. The Menkes copper transporter is required for the activation of tyrosinase. Hum. Mol. Genet. 9, 2845\u20132851 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"2192_CR93","doi-asserted-by":"publisher","first-page":"C933","DOI":"10.1152\/ajpcell.00151.2020","volume":"319","author":"V Sudhahar","year":"2020","unstructured":"Sudhahar, V. et al. Caveolin-1 stabilizes ATP7A, a copper transporter for extracellular SOD, in vascular tissue to maintain endothelial function. Am. J. Physiol. Cell Physiol. 319, C933\u2013c944 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2192_CR94","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1073\/pnas.1817473116","volume":"116","author":"V Shanbhag","year":"2019","unstructured":"Shanbhag, V. et al. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis. Proc. Natl. Acad. Sci. USA 116, 6836\u20136841 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR95","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1177\/1535370216645412","volume":"241","author":"L Wang","year":"2016","unstructured":"Wang, L., Ge, Y. & Kang, Y. J. Featured article: effect of copper on nuclear translocation of copper chaperone for superoxide dismutase-1. Exp. Biol. Med. 241, 1483\u20131488 (2016).","journal-title":"Exp. Biol. Med."},{"key":"2192_CR96","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1074\/jbc.M709463200","volume":"283","author":"S Itoh","year":"2008","unstructured":"Itoh, S. et al. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J. Biol. Chem. 283, 9157\u20139167 (2008).","journal-title":"J. Biol. Chem."},{"key":"2192_CR97","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.biocel.2008.08.001","volume":"41","author":"PA Muller","year":"2009","unstructured":"Muller, P. A. & Klomp, L. W. ATOX1: a novel copper-responsive transcription factor in mammals? Int. J. Biochem. Cell Biol. 41, 1233\u20131236 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2192_CR98","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/mol.108.051516","volume":"75","author":"W Feng","year":"2009","unstructured":"Feng, W. et al. Copper regulation of hypoxia-inducible factor-1 activity. Mol. Pharm. 75, 174\u2013182 (2009).","journal-title":"Mol. Pharm."},{"key":"2192_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag, V. C. et al. Copper metabolism as a unique vulnerability in cancer. Biochim. Biophys. Acta Mol. Cell Res. 1868, 118893 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"2192_CR100","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1039\/C5MT00149H","volume":"7","author":"D Denoyer","year":"2015","unstructured":"Denoyer, D., Masaldan, S., La Fontaine, S. & Cater, M. A. Targeting copper in cancer therapy: \u2018Copper That Cancer\u2019. Metallomics 7, 1459\u20131476 (2015).","journal-title":"Metallomics"},{"key":"2192_CR101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1746-160X-2-33","volume":"2","author":"SS Khanna","year":"2006","unstructured":"Khanna, S. S. & Karjodkar, F. R. Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial. Head. Face Med 2, 33 (2006).","journal-title":"Head. Face Med"},{"key":"2192_CR102","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12011-016-0768-2","volume":"175","author":"AK Baltaci","year":"2017","unstructured":"Baltaci, A. K., Dundar, T. K., Aksoy, F. & Mogulkoc, R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol. Trace Elem. Res. 175, 57\u201364 (2017).","journal-title":"Biol. Trace Elem. Res."},{"key":"2192_CR103","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10147-011-0327-y","volume":"17","author":"JF Feng","year":"2012","unstructured":"Feng, J. F. et al. Serum total oxidant\/antioxidant status and trace element levels in breast cancer patients. Int. J. Clin. Oncol. 17, 575\u2013583 (2012).","journal-title":"Int. J. Clin. Oncol."},{"key":"2192_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/BTER:89:1:1","volume":"89","author":"HW Kuo","year":"2002","unstructured":"Kuo, H. W. et al. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol. Trace Elem. Res. 89, 1\u201311 (2002).","journal-title":"Biol. Trace Elem. Res."},{"key":"2192_CR105","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canep.2010.06.004","volume":"35","author":"Y Jin","year":"2011","unstructured":"Jin, Y. et al. Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: a hospital-based case-control study in China. Cancer Epidemiol. 35, 182\u2013187 (2011).","journal-title":"Cancer Epidemiol."},{"key":"2192_CR106","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.redox.2021.101900","volume":"42","author":"K Lossow","year":"2021","unstructured":"Lossow, K., Schwarz, M. & Kipp, A. P. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 42, 101900 (2021).","journal-title":"Redox Biol."},{"key":"2192_CR107","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4143\/crt.2015.282","volume":"48","author":"MR Lener","year":"2016","unstructured":"Lener, M. R. et al. Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Res. Treat. 48, 1056\u20131064 (2016).","journal-title":"Cancer Res. Treat."},{"key":"2192_CR108","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00268-013-2164-9","volume":"37","author":"S Basu","year":"2013","unstructured":"Basu, S. et al. Heavy and trace metals in carcinoma of the gallbladder. World J. Surg. 37, 2641\u20132646 (2013).","journal-title":"World J. Surg."},{"key":"2192_CR109","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.2930520311","volume":"52","author":"SK Gupta","year":"1993","unstructured":"Gupta, S. K. et al. Serum and tissue trace elements in colorectal cancer. J. Surg. Oncol. 52, 172\u2013175 (1993).","journal-title":"J. Surg. Oncol."},{"key":"2192_CR110","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000499261","volume":"14","author":"SAK Saleh","year":"2020","unstructured":"Saleh, S. A. K., Adly, H. M., Abdelkhaliq, A. A. & Nassir, A. M. Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr. Urol. 14, 44\u201349 (2020).","journal-title":"Curr. Urol."},{"key":"2192_CR111","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1525-1438.2006.00742.x","volume":"17","author":"M Yaman","year":"2007","unstructured":"Yaman, M., Kaya, G. & Simsek, M. Comparison of trace element concentrations in cancerous and noncancerous human endometrial and ovary tissues. Int. J. Gynecol. Cancer 17, 220\u2013228 (2007).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"2192_CR112","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/cdd.2009.132","volume":"17","author":"ZX Chen","year":"2010","unstructured":"Chen, Z. X. & Pervaiz, S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. 17, 408\u2013420 (2010).","journal-title":"Cell Death Differ."},{"key":"2192_CR113","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.chembiol.2018.02.010","volume":"25","author":"K Shimada","year":"2018","unstructured":"Shimada, K. et al. Copper-binding small molecule induces oxidative stress and cell-cycle arrest in glioblastoma-patient-derived cells. Cell Chem. Biol. 25, 585\u2013594.e587 (2018).","journal-title":"Cell Chem. Biol."},{"key":"2192_CR114","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Cuproptosis: harnessing transition metal for cancer therapy. ACS Nano 17, 19581\u201319599 (2023).","journal-title":"ACS Nano"},{"key":"2192_CR115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah, R., Yin, Q., Snell, A. H. & Wan, L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin. Cancer Biol. 85, 123\u2013154 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2192_CR116","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar, M. E., Kim, H. J. & Kim, D. R. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct. Target Ther. 8, 455 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2192_CR117","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1128\/MCB.05722-11","volume":"32","author":"ML Turski","year":"2012","unstructured":"Turski, M. L. et al. A novel role for copper in Ras\/mitogen-activated protein kinase signaling. Mol. Cell Biol. 32, 1284\u20131295 (2012).","journal-title":"Mol. Cell Biol."},{"key":"2192_CR118","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jmb.2008.08.080","volume":"383","author":"MD Mattie","year":"2008","unstructured":"Mattie, M. D., McElwee, M. K. & Freedman, J. H. Mechanism of copper-activated transcription: activation of AP-1, and the JNK\/SAPK and p38 signal transduction pathways. J. Mol. Biol. 383, 1008\u20131018 (2008).","journal-title":"J. Mol. Biol."},{"key":"2192_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101314","volume":"297","author":"M Grasso","year":"2021","unstructured":"Grasso, M. et al. The copper chaperone CCS facilitates copper binding to MEK1\/2 to promote kinase activation. J. Biol. Chem. 297, 101314 (2021).","journal-title":"J. Biol. Chem."},{"key":"2192_CR120","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1158\/1541-7786.MCR-21-0250","volume":"20","author":"T Tsang","year":"2022","unstructured":"Tsang, T. et al. BRAFV600E-driven lung adenocarcinoma requires copper to sustain autophagic signaling and processing. Mol. Cancer Res. 20, 1096\u20131107 (2022).","journal-title":"Mol. Cancer Res."},{"key":"2192_CR121","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady, D. C. et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 509, 492\u2013496 (2014).","journal-title":"Nature"},{"key":"2192_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17549-y","volume":"11","author":"L Aubert","year":"2020","unstructured":"Aubert, L. et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat. Commun. 11, 3701 (2020).","journal-title":"Nat. Commun."},{"key":"2192_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004303","volume":"8","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Copper promotes tumorigenesis by activating the PDK1-AKT oncogenic pathway in a copper transporter 1-dependent manner. Adv. Sci. 8, e2004303 (2021).","journal-title":"Adv. Sci."},{"key":"2192_CR124","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Mari\u00f1o, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280\u2013293 (2010).","journal-title":"Mol. Cell"},{"key":"2192_CR125","doi-asserted-by":"crossref","unstructured":"Liu, G. et al. Role of autophagy and apoptosis in non-small-cell lung cancer. Int. J. Mol. Sci. 18, (2017).","DOI":"10.3390\/ijms18020367"},{"key":"2192_CR126","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.isci.2018.09.012","volume":"8","author":"KR Martin","year":"2018","unstructured":"Martin, K. R. et al. A potent and selective ULK1 inhibitor suppresses autophagy and sensitizes cancer cells to nutrient stress. iScience 8, 74\u201384 (2018).","journal-title":"iScience"},{"key":"2192_CR127","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1053\/j.gastro.2018.11.032","volume":"156","author":"EV Polishchuk","year":"2019","unstructured":"Polishchuk, E. V. et al. Activation of autophagy, observed in liver tissues from patients with Wilson disease and from atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology 156, 1173\u20131189.e1175 (2019).","journal-title":"Gastroenterology"},{"key":"2192_CR128","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"T Tsang","year":"2020","unstructured":"Tsang, T. et al. Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat. Cell Biol. 22, 412\u2013424 (2020).","journal-title":"Nat. Cell Biol."},{"key":"2192_CR129","doi-asserted-by":"publisher","first-page":"25346","DOI":"10.1002\/anie.202108961","volume":"60","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. APEX2-based proximity labeling of Atox1 identifies CRIP2 as a nuclear copper-binding protein that regulates autophagy activation. Angew. Chem. Int. Ed. Engl. 60, 25346\u201325355 (2021).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2192_CR130","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","volume":"14","author":"J Hu","year":"2021","unstructured":"Hu, J. et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J. Hematol. Oncol. 14, 157 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2192_CR131","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","volume":"24","author":"S Peuget","year":"2024","unstructured":"Peuget, S., Zhou, X. & Selivanova, G. Translating p53-based therapies for cancer into the clinic. Nat. Rev. Cancer 24, 192\u2013215 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2192_CR132","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.drudis.2015.07.006","volume":"20","author":"AR Blanden","year":"2015","unstructured":"Blanden, A. R. et al. Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer. Drug Discov. Today 20, 1391\u20131397 (2015).","journal-title":"Drug Discov. Today"},{"key":"2192_CR133","doi-asserted-by":"crossref","unstructured":"Alfadul, S. M., Matnurov, E. M., Varakutin, A. E. & Babak, M. V. Metal-based anticancer complexes and P53: how much do we know? Cancers 15, (2023).","DOI":"10.3390\/cancers15102834"},{"key":"2192_CR134","doi-asserted-by":"publisher","first-page":"e7052","DOI":"10.1371\/journal.pone.0007052","volume":"4","author":"F Arnesano","year":"2009","unstructured":"Arnesano, F. et al. Copper-triggered aggregation of ubiquitin. PLoS One 4, e7052 (2009).","journal-title":"PLoS One"},{"key":"2192_CR135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/cdd.2009.81","volume":"17","author":"S Galb\u00e1n","year":"2010","unstructured":"Galb\u00e1n, S. & Duckett, C. S. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 17, 54\u201360 (2010).","journal-title":"Cell Death Differ."},{"key":"2192_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14698-y","volume":"11","author":"Y Liao","year":"2020","unstructured":"Liao, Y. et al. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis. Nat. Commun. 11, 900 (2020).","journal-title":"Nat. Commun."},{"key":"2192_CR137","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.livres.2017.08.003","volume":"1","author":"DA Kieffer","year":"2017","unstructured":"Kieffer, D. A. & Medici, V. Wilson disease: at the crossroads between genetics and epigenetics-a review of the evidence. Liver Res. 1, 121\u2013130 (2017).","journal-title":"Liver Res."},{"key":"2192_CR138","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100183R","volume":"35","author":"X Jin","year":"2021","unstructured":"Jin, X. et al. Copper ions impair zebrafish skeletal myofibrillogenesis via epigenetic regulation. FASEB J. 35, e21686 (2021).","journal-title":"FASEB J."},{"key":"2192_CR139","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10456-021-09827-0","volume":"25","author":"Z Tai","year":"2022","unstructured":"Tai, Z., Li, L., Zhao, G. & Liu, J. X. Copper stress impairs angiogenesis and lymphangiogenesis during zebrafish embryogenesis by down-regulating pERK1\/2-foxm1-MMP2\/9 axis and epigenetically regulating ccbe1 expression. Angiogenesis 25, 241\u2013257 (2022).","journal-title":"Angiogenesis"},{"key":"2192_CR140","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.molcel.2006.05.040","volume":"23","author":"H Takahashi","year":"2006","unstructured":"Takahashi, H., McCaffery, J. M., Irizarry, R. A. & Boeke, J. D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23, 207\u2013217 (2006).","journal-title":"Mol. Cell"},{"key":"2192_CR141","doi-asserted-by":"publisher","first-page":"a019521","DOI":"10.1101\/cshperspect.a019521","volume":"8","author":"JE Audia","year":"2016","unstructured":"Audia, J. E. & Campbell, R. M. Histone modifications and cancer. Cold Spring Harb. Perspect. Biol. 8, a019521 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2192_CR142","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cbi.2004.05.003","volume":"148","author":"J Kang","year":"2004","unstructured":"Kang, J., Lin, C., Chen, J. & Liu, Q. Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity. Chem. Biol. Interact. 148, 115\u2013123 (2004).","journal-title":"Chem. Biol. Interact."},{"key":"2192_CR143","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.stem.2020.04.010","volume":"26","author":"RP Singh","year":"2020","unstructured":"Singh, R. P. et al. Disrupting mitochondrial copper distribution inhibits leukemic stem cell self-renewal. Cell Stem Cell 26, 926\u2013937.e910 (2020).","journal-title":"Cell Stem Cell"},{"key":"2192_CR144","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-33-6785-2_3","volume":"1316","author":"K Ma","year":"2021","unstructured":"Ma, K. & Zhang, L. Overview: lipid metabolism in the tumor microenvironment. Adv. Exp. Med. Biol. 1316, 41\u201347 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2192_CR145","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cellsig.2005.08.009","volume":"18","author":"GY Carmen","year":"2006","unstructured":"Carmen, G. Y. & V\u00edctor, S. M. Signalling mechanisms regulating lipolysis. Cell Signal 18, 401\u2013408 (2006).","journal-title":"Cell Signal"},{"key":"2192_CR146","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.2098","volume":"12","author":"L Krishnamoorthy","year":"2016","unstructured":"Krishnamoorthy, L. et al. Copper regulates cyclic-AMP-dependent lipolysis. Nat. Chem. Biol. 12, 586\u2013592 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"2192_CR147","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu, Z. L. et al. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct. Target Ther. 8, 198 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2192_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114806","volume":"163","author":"X Li","year":"2023","unstructured":"Li, X. et al. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis. Biomed. Pharmacother. 163, 114806 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2192_CR149","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0014-4827(80)90051-8","volume":"130","author":"BR McAuslan","year":"1980","unstructured":"McAuslan, B. R. & Reilly, W. Endothelial cell phagokinesis in response to specific metal ions. Exp. Cell Res. 130, 147\u2013157 (1980).","journal-title":"Exp. Cell Res."},{"key":"2192_CR150","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A","volume":"69","author":"GF Hu","year":"1998","unstructured":"Hu, G. F. Copper stimulates proliferation of human endothelial cells under culture. J. Cell Biochem. 69, 326\u2013335 (1998).","journal-title":"J. Cell Biochem."},{"key":"2192_CR151","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. The role of microenvironment in tumor angiogenesis. J. Exp. Clin. Cancer Res. 39, 204 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2192_CR152","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1006\/bbrc.1997.7018","volume":"236","author":"F Soncin","year":"1997","unstructured":"Soncin, F., Guitton, J. D., Cartwright, T. & Badet, J. Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem. Biophys. Res. Commun. 236, 604\u2013610 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2192_CR153","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biocel.2015.01.005","volume":"60","author":"C Giacomelli","year":"2015","unstructured":"Giacomelli, C. et al. \u2666Copper (II) ions modulate Angiogenin activity in human endothelial cells. Int. J. Biochem. Cell Biol. 60, 185\u2013196 (2015).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2192_CR154","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1074\/jbc.RA118.001764","volume":"293","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Copper levels affect targeting of hypoxia-inducible factor 1\u03b1 to the promoters of hypoxia-regulated genes. J. Biol. Chem. 293, 14669\u201314677 (2018).","journal-title":"J. Biol. Chem."},{"key":"2192_CR155","first-page":"4854","volume":"62","author":"Q Pan","year":"2002","unstructured":"Pan, Q. et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 62, 4854\u20134859 (2002).","journal-title":"Cancer Res."},{"key":"2192_CR156","doi-asserted-by":"publisher","first-page":"34158","DOI":"10.18632\/oncotarget.5779","volume":"6","author":"DC Rigiracciolo","year":"2015","unstructured":"Rigiracciolo, D. C. et al. Copper activates HIF-1\u03b1\/GPER\/VEGF signalling in cancer cells. Oncotarget 6, 34158\u201334177 (2015).","journal-title":"Oncotarget"},{"key":"2192_CR157","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000438485","volume":"52","author":"E Urso","year":"2015","unstructured":"Urso, E. & Maffia, M. Behind the link between copper and angiogenesis: established mechanisms and an overview on the role of vascular copper transport systems. J. Vasc. Res. 52, 172\u2013196 (2015).","journal-title":"J. Vasc. Res."},{"key":"2192_CR158","doi-asserted-by":"publisher","first-page":"e71982","DOI":"10.1371\/journal.pone.0071982","volume":"8","author":"G Narayanan","year":"2013","unstructured":"Narayanan, G. et al. CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells. PLoS One 8, e71982 (2013).","journal-title":"PLoS One"},{"key":"2192_CR159","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/ATVBAHA.112.300862","volume":"33","author":"T Kohno","year":"2013","unstructured":"Kohno, T. et al. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury. Arterioscler. Thromb. Vasc. Biol. 33, 805\u2013813 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2192_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23408-1","volume":"12","author":"D Ash","year":"2021","unstructured":"Ash, D. et al. The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2. Nat. Commun. 12, 3091 (2021).","journal-title":"Nat. Commun."},{"key":"2192_CR161","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ajpath.2011.01.011","volume":"178","author":"S Nakao","year":"2011","unstructured":"Nakao, S. et al. VAP-1-mediated M2 macrophage infiltration underlies IL-1\u03b2- but not VEGF-A-induced lymph- and angiogenesis. Am. J. Pathol. 178, 1913\u20131921 (2011).","journal-title":"Am. J. Pathol."},{"key":"2192_CR162","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3164\/jcbn.22-9","volume":"71","author":"T Kamiya","year":"2022","unstructured":"Kamiya, T. Copper in the tumor microenvironment and tumor metastasis. J. Clin. Biochem. Nutr. 71, 22\u201328 (2022).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"2192_CR163","doi-asserted-by":"publisher","first-page":"1186659","DOI":"10.3389\/fonc.2023.1186659","volume":"13","author":"C Zhou","year":"2023","unstructured":"Zhou, C. et al. Copper metabolism and hepatocellular carcinoma: current insights. Front. Oncol. 13, 1186659 (2023).","journal-title":"Front. Oncol."},{"key":"2192_CR164","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda, M. et al. Mechanisms of cancer metastasis. Semin. Cancer Biol. 87, 17\u201331 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2192_CR165","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/C6MT00202A","volume":"9","author":"S Blockhuys","year":"2017","unstructured":"Blockhuys, S. et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics 9, 112\u2013123 (2017).","journal-title":"Metallomics"},{"key":"2192_CR166","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1158\/1535-7163.MCT-06-0524","volume":"6","author":"B Hassouneh","year":"2007","unstructured":"Hassouneh, B. et al. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol. Cancer Ther. 6, 1039\u20131045 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"2192_CR167","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3319","volume":"12","author":"HE Barker","year":"2012","unstructured":"Barker, H. E., Cox, T. R. & Erler, J. T. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 12, 540\u2013552 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2192_CR168","doi-asserted-by":"crossref","unstructured":"Laczko, R. & Csiszar, K. Lysyl Oxidase (LOX): functional contributions to signaling pathways. Biomolecules 10, (2020).","DOI":"10.3390\/biom10081093"},{"key":"2192_CR169","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12307-012-0105-z","volume":"5","author":"Q Xiao","year":"2012","unstructured":"Xiao, Q. & Ge, G. Lysyl oxidase, extracellular matrix remodeling and cancer metastasis. Cancer Microenviron. 5, 261\u2013273 (2012).","journal-title":"Cancer Microenviron."},{"key":"2192_CR170","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","volume":"15","author":"JT Erler","year":"2009","unstructured":"Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35\u201344 (2009).","journal-title":"Cancer Cell"},{"key":"2192_CR171","first-page":"1820","volume":"115","author":"D Al-U\u2019datt","year":"2019","unstructured":"Al-U\u2019datt, D., Allen, B. G. & Nattel, S. Role of the lysyl oxidase enzyme family in cardiac function and disease. Cardiovasc. Res. 115, 1820\u20131837 (2019).","journal-title":"Cardiovasc. Res."},{"key":"2192_CR172","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1158\/0008-5472.CAN-19-0860","volume":"79","author":"XH Zhan","year":"2019","unstructured":"Zhan, X. H. et al. LOXL2 upregulates phosphorylation of ezrin to promote cytoskeletal reorganization and tumor cell invasion. Cancer Res. 79, 4951\u20134964 (2019).","journal-title":"Cancer Res."},{"key":"2192_CR173","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.gendis.2021.12.016","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma. Genes Dis. 10, 254\u2013266 (2023).","journal-title":"Genes Dis."},{"key":"2192_CR174","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.2004870","volume":"7","author":"G MacDonald","year":"2014","unstructured":"MacDonald, G. et al. Memo is a copper-dependent redox protein with an essential role in migration and metastasis. Sci. Signal 7, ra56 (2014).","journal-title":"Sci. Signal"},{"key":"2192_CR175","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206905119","volume":"119","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro. Proc. Natl. Acad. Sci. USA 119, e2206905119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR176","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41417-020-00279-0","volume":"28","author":"M Murdocca","year":"2021","unstructured":"Murdocca, M. et al. LOX-1 and cancer: an indissoluble liaison. Cancer Gene Ther. 28, 1088\u20131098 (2021).","journal-title":"Cancer Gene Ther."},{"key":"2192_CR177","doi-asserted-by":"publisher","first-page":"16369","DOI":"10.1073\/pnas.1113483108","volume":"108","author":"CC Wong","year":"2011","unstructured":"Wong, C. C. et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc. Natl. Acad. Sci. USA 108, 16369\u201316374 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR178","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-10-1516","volume":"71","author":"F Pez","year":"2011","unstructured":"Pez, F. et al. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 71, 1647\u20131657 (2011).","journal-title":"Cancer Res."},{"key":"2192_CR179","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1182\/blood-2004-10-3980","volume":"105","author":"F Martin","year":"2005","unstructured":"Martin, F. et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 105, 4613\u20134619 (2005).","journal-title":"Blood"},{"key":"2192_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/srep12410","volume":"5","author":"S Li","year":"2015","unstructured":"Li, S. et al. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail\/Twist-mediated epithelial-mesenchymal transition. Sci. Rep. 5, 12410 (2015).","journal-title":"Sci. Rep."},{"key":"2192_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani, D. et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat. Commun. 12, 7311 (2021).","journal-title":"Nat. Commun."},{"key":"2192_CR182","doi-asserted-by":"publisher","first-page":"51151","DOI":"10.18632\/oncotarget.17712","volume":"8","author":"P Ding","year":"2017","unstructured":"Ding, P. et al. CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells. Oncotarget 8, 51151\u201351163 (2017).","journal-title":"Oncotarget"},{"key":"2192_CR183","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1073\/pnas.1910722117","volume":"117","author":"S Blockhuys","year":"2020","unstructured":"Blockhuys, S., Zhang, X. & Wittung-Stafshede, P. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration. Proc. Natl. Acad. Sci. USA 117, 2014\u20132019 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR184","doi-asserted-by":"publisher","first-page":"22826","DOI":"10.1074\/jbc.M706563200","volume":"283","author":"MS Weaver","year":"2008","unstructured":"Weaver, M. S., Workman, G. & Sage, E. H. The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase. J. Biol. Chem. 283, 22826\u201322837 (2008).","journal-title":"J. Biol. Chem."},{"key":"2192_CR185","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/carcin\/bgu072","volume":"35","author":"GP Nagaraju","year":"2014","unstructured":"Nagaraju, G. P., Dontula, R., El-Rayes, B. F. & Lakka, S. S. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. Carcinogenesis 35, 967\u2013973 (2014).","journal-title":"Carcinogenesis"},{"key":"2192_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi, M. et al. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol. Cancer 21, 28 (2022).","journal-title":"Mol. Cancer"},{"key":"2192_CR187","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun, C., Mezzadra, R. & Schumacher, T. N. Regulation and function of the PD-L1 checkpoint. Immunity 48, 434\u2013452 (2018).","journal-title":"Immunity"},{"key":"2192_CR188","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","volume":"14","author":"M Yi","year":"2021","unstructured":"Yi, M. et al. Regulation of PD-L1 expression in the tumor microenvironment. J. Hematol. Oncol. 14, 10 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2192_CR189","doi-asserted-by":"publisher","first-page":"1019153","DOI":"10.3389\/fonc.2022.1019153","volume":"12","author":"F Cheng","year":"2022","unstructured":"Cheng, F. et al. Relationship between copper and immunity: the potential role of copper in tumor immunity. Front. Oncol. 12, 1019153 (2022).","journal-title":"Front. Oncol."},{"key":"2192_CR190","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/hep.31600","volume":"73","author":"HY Tan","year":"2021","unstructured":"Tan, H. Y. et al. Lysyl oxidase-like 4 fosters an immunosuppressive microenvironment during hepatocarcinogenesis. Hepatology 73, 2326\u20132341 (2021).","journal-title":"Hepatology"},{"key":"2192_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang, X. et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol. Cancer 18, 10 (2019).","journal-title":"Mol. Cancer"},{"key":"2192_CR192","first-page":"2442","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou, B. et al. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. Am. J. Cancer Res. 9, 2442\u20132455 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"2192_CR193","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17, 395\u2013417 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2192_CR194","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"2192_CR195","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/BST20210751","volume":"50","author":"S Kumar","year":"2022","unstructured":"Kumar, S., Dorstyn, L. & Lim, Y. The role of caspases as executioners of apoptosis. Biochem. Soc. Trans. 50, 33\u201345 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"2192_CR196","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1530\/REP-14-0422","volume":"149","author":"KJ Hutt","year":"2015","unstructured":"Hutt, K. J. The role of BH3-only proteins in apoptosis within the ovary. Reproduction 149, R81\u201389 (2015).","journal-title":"Reproduction"},{"key":"2192_CR197","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"2192_CR198","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/BTER:96:1-3:209","volume":"96","author":"D Ozcelik","year":"2003","unstructured":"Ozcelik, D. et al. Copper-mediated oxidative stress in rat liver. Biol. Trace Elem. Res. 96, 209\u2013215 (2003).","journal-title":"Biol. Trace Elem. Res."},{"key":"2192_CR199","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tiv.2018.10.017","volume":"54","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes. Toxicol. Vitr. 54, 310\u2013316 (2019).","journal-title":"Toxicol. Vitr."},{"key":"2192_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00548-3","volume":"18","author":"G Zhao","year":"2020","unstructured":"Zhao, G., Sun, H., Zhang, T. & Liu, J. X. Copper induce zebrafish retinal developmental defects via triggering stresses and apoptosis. Cell Commun. Signal 18, 45 (2020).","journal-title":"Cell Commun. Signal"},{"key":"2192_CR201","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.fct.2008.02.014","volume":"46","author":"M Kawakami","year":"2008","unstructured":"Kawakami, M. et al. Mechanism of apoptosis induced by copper in PC12 cells. Food Chem. Toxicol. 46, 2157\u20132164 (2008).","journal-title":"Food Chem. Toxicol."},{"key":"2192_CR202","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10495-005-6066-7","volume":"10","author":"EA Ostrakhovitch","year":"2005","unstructured":"Ostrakhovitch, E. A. & Cherian, M. G. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Apoptosis 10, 111\u2013121 (2005).","journal-title":"Apoptosis"},{"key":"2192_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.110236","volume":"191","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways. Ecotoxicol. Environ. Saf. 191, 110236 (2020).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"2192_CR204","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s10495-021-01692-y","volume":"26","author":"CH Chen","year":"2021","unstructured":"Chen, C. H., Chou, Y. T., Yang, Y. W. & Lo, K. Y. High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines. Apoptosis 26, 612\u2013627 (2021).","journal-title":"Apoptosis"},{"key":"2192_CR205","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen, D., Cui, Q. C., Yang, H. & Dou, Q. P. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 66, 10425\u201310433 (2006).","journal-title":"Cancer Res."},{"key":"2192_CR206","volume":"2020","author":"H Liu","year":"2020","unstructured":"Liu, H. et al. Copper induces oxidative stress and apoptosis in the mouse liver. Oxid. Med. Cell Longev. 2020, 1359164 (2020).","journal-title":"Oxid. Med. Cell Longev."},{"key":"2192_CR207","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.1021\/jm301053a","volume":"55","author":"S Tardito","year":"2012","unstructured":"Tardito, S. et al. Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation. J. Med. Chem. 55, 10448\u201310459 (2012).","journal-title":"J. Med. Chem."},{"key":"2192_CR208","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao, Z. et al. Pyroptosis in inflammatory diseases and cancer. Theranostics 12, 4310\u20134329 (2022).","journal-title":"Theranostics"},{"key":"2192_CR209","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs, S. B. & Miao, E. A. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 27, 673\u2013684 (2017).","journal-title":"Trends Cell Biol."},{"key":"2192_CR210","doi-asserted-by":"publisher","first-page":"121498","DOI":"10.1016\/j.lfs.2023.121498","volume":"318","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Wang, C. & Lin, C. Pyroptosis as a double-edged sword: the pathogenic and therapeutic roles in inflammatory diseases and cancers. Life Sci. 318, 121498 (2023).","journal-title":"Life Sci."},{"key":"2192_CR211","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41581-022-00662-0","volume":"19","author":"EE Elias","year":"2023","unstructured":"Elias, E. E., Lyons, B. & Muruve, D. A. Gasdermins and pyroptosis in the kidney. Nat. Rev. Nephrol. 19, 337\u2013350 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"2192_CR212","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll, R. C., Schroder, K. & Pelegr\u00edn, P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharm. Sci. 43, 653\u2013668 (2022).","journal-title":"Trends Pharm. Sci."},{"key":"2192_CR213","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ecoenv.2019.02.069","volume":"174","author":"J Liao","year":"2019","unstructured":"Liao, J. et al. Inhibition of Caspase-1-dependent pyroptosis attenuates copper-induced apoptosis in chicken hepatocytes. Ecotoxicol. Environ. Saf. 174, 110\u2013119 (2019).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"2192_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113369","volume":"168","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Copper induces microglia-mediated neuroinflammation through ROS\/NF-\u03baB pathway and mitophagy disorder. Food Chem. Toxicol. 168, 113369 (2022).","journal-title":"Food Chem. Toxicol."},{"key":"2192_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.125134","volume":"411","author":"X Tao","year":"2021","unstructured":"Tao, X. et al. A tandem activation of NLRP3 inflammasome induced by copper oxide nanoparticles and dissolved copper ion in J774A.1 macrophage. J. Hazard Mater. 411, 125134 (2021).","journal-title":"J. Hazard Mater."},{"key":"2192_CR216","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/acs.jafc.1c07927","volume":"70","author":"J Liao","year":"2022","unstructured":"Liao, J. et al. Endoplasmic reticulum stress contributes to copper-induced pyroptosis via regulating the IRE1\u03b1-XBP1 pathway in pig jejunal epithelial cells. J. Agric. Food Chem. 70, 1293\u20131303 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"2192_CR217","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","volume":"12","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Kepp, O., Chan, F. K. & Kroemer, G. Necroptosis: mechanisms and relevance to disease. Annu. Rev. Pathol. 12, 103\u2013130 (2017).","journal-title":"Annu. Rev. Pathol."},{"key":"2192_CR218","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tips.2016.12.005","volume":"38","author":"KW Wegner","year":"2017","unstructured":"Wegner, K. W., Saleh, D. & Degterev, A. Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis. Trends Pharm. Sci. 38, 202\u2013225 (2017).","journal-title":"Trends Pharm. Sci."},{"key":"2192_CR219","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan, J., Wan, P., Choksi, S. & Liu, Z. G. Necroptosis and tumor progression. Trends Cancer 8, 21\u201327 (2022).","journal-title":"Trends Cancer"},{"key":"2192_CR220","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","volume":"54","author":"MJ Morgan","year":"2022","unstructured":"Morgan, M. J. & Kim, Y. S. Roles of RIPK3 in necroptosis, cell signaling, and disease. Exp. Mol. Med. 54, 1695\u20131704 (2022).","journal-title":"Exp. Mol. Med."},{"key":"2192_CR221","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/thno.54072","volume":"11","author":"C Zhan","year":"2021","unstructured":"Zhan, C., Huang, M., Yang, X. & Hou, J. MLKL: functions beyond serving as the executioner of necroptosis. Theranostics11, 4759\u20134769 (2021).","journal-title":"Theranostics"},{"key":"2192_CR222","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Wang, Y., Inuzuka, H. & Wei, W. Necroptosis pathways in tumorigenesis. Semin. Cancer Biol. 86, 32\u201340 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2192_CR223","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41420-023-01641-5","volume":"9","author":"S Tang","year":"2023","unstructured":"Tang, S. et al. ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis. Cell Death Discov. 9, 344 (2023).","journal-title":"Cell Death Discov."},{"key":"2192_CR224","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/17435390.2020.1759727","volume":"14","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. CuS-NiS(2) nanomaterials for MRI-guided phototherapy of gastric carcinoma via triggering mitochondria-mediated apoptosis and MLKL\/CAPG-mediated necroptosis. Nanotoxicology 14, 774\u2013787 (2020).","journal-title":"Nanotoxicology"},{"key":"2192_CR225","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct. Target Ther. 9, 55 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2192_CR226","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2192_CR227","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2192_CR228","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu, J., Kang, R. & Tang, D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 289, 7038\u20137050 (2022).","journal-title":"FEBS J."},{"key":"2192_CR229","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini, F. & Maiorino, M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic. Biol. Med. 152, 175\u2013185 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR230","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0891-5849(89)90160-3","volume":"6","author":"HC Sutton","year":"1989","unstructured":"Sutton, H. C. & Winterbourn, C. C. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic. Biol. Med. 6, 53\u201360 (1989).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR231","doi-asserted-by":"publisher","first-page":"19823","DOI":"10.1021\/ja206980q","volume":"133","author":"L Qiao","year":"2011","unstructured":"Qiao, L., Lu, Y., Liu, B. & Girault, H. H. Copper-catalyzed tyrosine nitration. J. Am. Chem. Soc. 133, 19823\u201319831 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"2192_CR232","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"2192_CR233","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao, W. et al. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol. Oncol. 15, 3527\u20133544 (2021).","journal-title":"Mol. Oncol."},{"key":"2192_CR234","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Disulfiram\/copper induces antitumor activity against both nasopharyngeal cancer cells and cancer-associated fibroblasts through ROS\/MAPK and ferroptosis pathways. Cancers. 12, (2020).","DOI":"10.3390\/cancers12010138"},{"key":"2192_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102122","volume":"46","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis. Redox Biol. 46, 102122 (2021).","journal-title":"Redox Biol."},{"key":"2192_CR236","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jhep.2022.01.009","volume":"76","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. COMMD10 inhibits HIF1\u03b1\/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. J. Hepatol. 76, 1138\u20131150 (2022).","journal-title":"J. Hepatol."},{"key":"2192_CR237","doi-asserted-by":"crossref","unstructured":"Li, F. et al. Copper Depletion strongly enhances ferroptosis via mitochondrial perturbation and reduction in antioxidative mechanisms. Antioxidants 11, (2022).","DOI":"10.3390\/antiox11112084"},{"key":"2192_CR238","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell 147, 728\u2013741 (2011).","journal-title":"Cell"},{"key":"2192_CR239","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine, B. & Kroemer, G. Biological functions of autophagy genes: a disease perspective. Cell 176, 11\u201342 (2019).","journal-title":"Cell"},{"key":"2192_CR240","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","volume":"56","author":"DR Miller","year":"2021","unstructured":"Miller, D. R. & Thorburn, A. Autophagy and organelle homeostasis in cancer. Dev. Cell 56, 906\u2013918 (2021).","journal-title":"Dev. Cell"},{"key":"2192_CR241","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38401-z","volume":"14","author":"JM Park","year":"2023","unstructured":"Park, J. M., Lee, D. H. & Kim, D. H. Redefining the role of AMPK in autophagy and the energy stress response. Nat. Commun. 14, 2994 (2023).","journal-title":"Nat. Commun."},{"key":"2192_CR242","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C. & Guan, K. L. mTOR: a pharmacologic target for autophagy regulation. J. Clin. Investig. 125, 25\u201332 (2015).","journal-title":"J. Clin. Investig."},{"key":"2192_CR243","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"2192_CR244","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semcancer.2013.05.007","volume":"23","author":"M Wirth","year":"2013","unstructured":"Wirth, M., Joachim, J. & Tooze, S. A. Autophagosome formation-the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 23, 301\u2013309 (2013).","journal-title":"Semin Cancer Biol."},{"key":"2192_CR245","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/15548627.2020.1749401","volume":"17","author":"P Dalle Pezze","year":"2021","unstructured":"Dalle Pezze, P. et al. ATG13 dynamics in nonselective autophagy and mitophagy: insights from live imaging studies and mathematical modeling. Autophagy 17, 1131\u20131141 (2021).","journal-title":"Autophagy"},{"key":"2192_CR246","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.chemosphere.2018.03.192","volume":"204","author":"F Yang","year":"2018","unstructured":"Yang, F. et al. Autophagy attenuates copper-induced mitochondrial dysfunction by regulating oxidative stress in chicken hepatocytes. Chemosphere 204, 36\u201343 (2018).","journal-title":"Chemosphere"},{"key":"2192_CR247","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2019.08.026","volume":"72","author":"Y Hazari","year":"2020","unstructured":"Hazari, Y. et al. Autophagy in hepatic adaptation to stress. J. Hepatol. 72, 183\u2013196 (2020).","journal-title":"J. Hepatol."},{"key":"2192_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102227","volume":"49","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. Induction of autophagy via the ROS-dependent AMPK-mTOR pathway protects copper-induced spermatogenesis disorder. Redox Biol. 49, 102227 (2022).","journal-title":"Redox Biol."},{"key":"2192_CR249","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","volume":"20","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy 20, 1213\u20131246 (2024).","journal-title":"Autophagy"},{"key":"2192_CR250","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem. Biol. 27, 420\u2013435 (2020).","journal-title":"Cell Chem. Biol."},{"key":"2192_CR251","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41418-020-00728-1","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Cellular degradation systems in ferroptosis. Cell Death Differ. 28, 1135\u20131148 (2021).","journal-title":"Cell Death Differ."},{"key":"2192_CR252","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1073\/pnas.1819728116","volume":"116","author":"Z Wu","year":"2019","unstructured":"Wu, Z. et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc. Natl. Acad. Sci. USA 116, 2996\u20133005 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR253","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15548627.2022.2059170","volume":"19","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy 19, 54\u201374 (2023).","journal-title":"Autophagy"},{"key":"2192_CR254","doi-asserted-by":"publisher","first-page":"e43442","DOI":"10.1371\/journal.pone.0043442","volume":"7","author":"T Sun","year":"2012","unstructured":"Sun, T. et al. Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS One 7, e43442 (2012).","journal-title":"PLoS One"},{"key":"2192_CR255","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.etp.2009.08.001","volume":"62","author":"WJ Guo","year":"2010","unstructured":"Guo, W. J. et al. ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complex. Exp. Toxicol. Pathol. 62, 577\u2013582 (2010).","journal-title":"Exp. Toxicol. Pathol."},{"key":"2192_CR256","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-023-06017-4","volume":"617","author":"S Solier","year":"2023","unstructured":"Solier, S. et al. A druggable copper-signalling pathway that drives inflammation. Nature 617, 386\u2013394 (2023).","journal-title":"Nature"},{"key":"2192_CR257","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2192_CR258","doi-asserted-by":"crossref","unstructured":"Gao, X. et al. Disulfiram\/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma. Cancers 14, (2022).","DOI":"10.3390\/cancers14194715"},{"key":"2192_CR259","doi-asserted-by":"crossref","unstructured":"Zheng, Z. et al. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery. J. Immunother Cancer. 8, (2020).","DOI":"10.1136\/jitc-2019-000207"},{"key":"2192_CR260","first-page":"e22","volume":"277","author":"EB Hart","year":"2002","unstructured":"Hart, E. B., Steenbock, H., Waddell, J. & Elvehjem, C. A. Iron in nutrition. VII. Copper as a supplement to iron for hemoglobin building in the rat. 1928. J. Biol. Chem. 277, e22 (2002).","journal-title":"J. Biol. Chem."},{"key":"2192_CR261","first-page":"649","volume":"24","author":"FB de Jorge","year":"1965","unstructured":"de Jorge, F. B., Canato, C. & Delascio, D. Biochemical studies on fibroleiomyoma. Matern Infanc. 24, 649\u2013654 (1965).","journal-title":"Matern Infanc."},{"key":"2192_CR262","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000455548","volume":"1","author":"NG Beratis","year":"1980","unstructured":"Beratis, N. G., Yee, M., LaBadie, G. U. & Hirschhorn, K. Effect of copper on Menkes\u2019 and normal cultured skin fibroblasts. Dev. Pharm. Ther. 1, 305\u2013317 (1980).","journal-title":"Dev. Pharm. Ther."},{"key":"2192_CR263","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2190001","volume":"219","author":"B Halliwell","year":"1984","unstructured":"Halliwell, B. & Gutteridge, J. M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1\u201314 (1984).","journal-title":"Biochem. J."},{"key":"2192_CR264","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/80.3.188","volume":"80","author":"ME B\u00e9gin","year":"1988","unstructured":"B\u00e9gin, M. E., Ells, G. & Horrobin, D. F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst. 80, 188\u2013194 (1988).","journal-title":"J. Natl. Cancer Inst."},{"key":"2192_CR265","first-page":"285","volume":"3","author":"I Haiduc","year":"1989","unstructured":"Haiduc, I. & Silvestru, C. Rhodium, iridium, copper and gold antitumor organometallic compounds (review). In Vivo 3, 285\u2013293 (1989).","journal-title":"In Vivo"},{"key":"2192_CR266","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF00686232","volume":"25","author":"E Monti","year":"1990","unstructured":"Monti, E. et al. Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate. Cancer Chemother. Pharm. 25, 333\u2013336 (1990).","journal-title":"Cancer Chemother. Pharm."},{"key":"2192_CR267","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1016\/S0021-9258(18)38132-8","volume":"266","author":"LK Tkeshelashvili","year":"1991","unstructured":"Tkeshelashvili, L. K., McBride, T., Spence, K. & Loeb, L. A. Mutation spectrum of copper-induced DNA damage. J. Biol. Chem. 266, 6401\u20136406 (1991).","journal-title":"J. Biol. Chem."},{"key":"2192_CR268","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ng0193-20","volume":"3","author":"JF Mercer","year":"1993","unstructured":"Mercer, J. F. et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3, 20\u201325 (1993).","journal-title":"Nat. Genet."},{"key":"2192_CR269","first-page":"57","volume":"102","author":"TM Reid","year":"1994","unstructured":"Reid, T. M., Feig, D. I. & Loeb, L. A. Mutagenesis by metal-induced oxygen radicals. Environ. Health Perspect. 102, 57\u201361 (1994).","journal-title":"Environ. Health Perspect."},{"key":"2192_CR270","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF01772204","volume":"126","author":"M Calderaro","year":"1993","unstructured":"Calderaro, M., Martins, E. A. & Meneghini, R. Oxidative stress by menadione affects cellular copper and iron homeostasis. Mol. Cell Biochem. 126, 17\u201323 (1993).","journal-title":"Mol. Cell Biochem."},{"key":"2192_CR271","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1006\/bbrc.1995.2700","volume":"216","author":"E Schnitzer","year":"1995","unstructured":"Schnitzer, E. et al. Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem. Biophys. Res. Commun. 216, 854\u2013861 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2192_CR272","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/jps.2600810703","volume":"81","author":"GJ Quinlan","year":"1992","unstructured":"Quinlan, G. J., Coudray, C., Hubbard, A. & Gutteridge, J. M. Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure. J. Pharm. Sci. 81, 611\u2013614 (1992).","journal-title":"J. Pharm. Sci."},{"key":"2192_CR273","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1097-4652(200008)184:2<161::AID-JCP3>3.0.CO;2-N","volume":"184","author":"Q Zhai","year":"2000","unstructured":"Zhai, Q. et al. Copper induces apoptosis in BA\/F3beta cells: Bax, reactive oxygen species, and NFkappaB are involved. J. Cell Physiol. 184, 161\u2013170 (2000).","journal-title":"J. Cell Physiol."},{"key":"2192_CR274","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00418-006-0183-4","volume":"126","author":"S Tardito","year":"2006","unstructured":"Tardito, S. et al. Non-apoptotic programmed cell death induced by a copper(II) complex in human fibrosarcoma cells. Histochem. Cell Biol. 126, 473\u2013482 (2006).","journal-title":"Histochem. Cell Biol."},{"key":"2192_CR275","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2007.01.005","volume":"167","author":"M Hultberg","year":"2007","unstructured":"Hultberg, M., Isaksson, A., Andersson, A. & Hultberg, B. Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content. Chem. Biol. Interact. 167, 56\u201362 (2007).","journal-title":"Chem. Biol. Interact."},{"key":"2192_CR276","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.devcel.2014.04.033","volume":"29","author":"EV Polishchuk","year":"2014","unstructured":"Polishchuk, E. V. et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev. Cell 29, 686\u2013700 (2014).","journal-title":"Dev. Cell"},{"key":"2192_CR277","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/14.2.365","volume":"14","author":"J Leiter","year":"1953","unstructured":"Leiter, J. et al. Damage induced in sarcoma 37 with chemical agents. VI. Biphenyl, fluorene, phenanthrene, and tropolone derivatives. J. Natl. Cancer Inst. 14, 365\u2013374 (1953).","journal-title":"J. Natl. Cancer Inst."},{"key":"2192_CR278","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/jnci\/52.5.1583","volume":"52","author":"LW Wattenberg","year":"1974","unstructured":"Wattenberg, L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds. J. Natl. Cancer Inst. 52, 1583\u20131587 (1974).","journal-title":"J. Natl. Cancer Inst."},{"key":"2192_CR279","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1021\/jm049568z","volume":"47","author":"D Cen","year":"2004","unstructured":"Cen, D. et al. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J. Med. Chem. 47, 6914\u20136920 (2004).","journal-title":"J. Med. Chem."},{"key":"2192_CR280","first-page":"1","volume":"6","author":"GJ Brewer","year":"2000","unstructured":"Brewer, G. J. et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin. Cancer Res. 6, 1\u201310 (2000).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0887-2333(99)00082-X","volume":"14","author":"A De Vizcaya-Ruiz","year":"2000","unstructured":"De Vizcaya-Ruiz, A. et al. Induction of apoptosis by a novel copper-based anticancer compound, Cassiopeia II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. Toxicol. Vitr. 14, 1\u20135 (2000).","journal-title":"Toxicol. Vitr."},{"key":"2192_CR282","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","volume":"7","author":"JR Kirshner","year":"2008","unstructured":"Kirshner, J. R. et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol. Cancer Ther. 7, 2319\u20132327 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"2192_CR283","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng, P. et al. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J. Exp. Clin. Cancer Res. 41, 271 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2192_CR284","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J. Cell Physiol. 231, 2570\u20132581 (2016).","journal-title":"J. Cell Physiol."},{"key":"2192_CR285","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai, M. et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic. Biol. Med. 52, 2142\u20132150 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR286","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.04.013","volume":"126","author":"AA Yadav","year":"2013","unstructured":"Yadav, A. A., Patel, D., Wu, X. & Hasinoff, B. B. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II). J. Inorg. Biochem. 126, 1\u20136 (2013).","journal-title":"J. Inorg. Biochem."},{"key":"2192_CR287","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2014.12.008","volume":"93","author":"BB Hasinoff","year":"2015","unstructured":"Hasinoff, B. B. et al. Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II). Biochem. Pharm. 93, 266\u2013276 (2015).","journal-title":"Biochem. Pharm."},{"key":"2192_CR288","doi-asserted-by":"publisher","first-page":"56933","DOI":"10.18632\/oncotarget.10921","volume":"7","author":"SY Kwan","year":"2016","unstructured":"Kwan, S. Y. et al. Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells. Oncotarget 7, 56933\u201356943 (2016).","journal-title":"Oncotarget"},{"key":"2192_CR289","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2015.07.029","volume":"369","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Copper improves the anti-angiogenic activity of disulfiram through the EGFR\/Src\/VEGF pathway in gliomas. Cancer Lett. 369, 86\u201396 (2015).","journal-title":"Cancer Lett."},{"key":"2192_CR290","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/sca.21332","volume":"38","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Scanning 38, 825\u2013836 (2016).","journal-title":"Scanning"},{"key":"2192_CR291","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott, Z. et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552, 194\u2013199 (2017).","journal-title":"Nature"},{"key":"2192_CR292","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20359-x","volume":"12","author":"M Pan","year":"2021","unstructured":"Pan, M. et al. Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative. Nat. Commun. 12, 121 (2021).","journal-title":"Nat. Commun."},{"key":"2192_CR293","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov, P. et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat. Chem. Biol. 15, 681\u2013689 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"2192_CR294","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-021-02031-4","volume":"40","author":"M Buccarelli","year":"2021","unstructured":"Buccarelli, M. et al. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J. Exp. Clin. Cancer Res. 40, 228 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2192_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).","journal-title":"Nat. Commun."},{"key":"2192_CR296","doi-asserted-by":"crossref","unstructured":"Liu, Y. T. et al. Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 31, 1452\u20131466 (2024).","DOI":"10.1038\/s41418-024-01341-2"},{"key":"2192_CR297","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Zinc transporter 1 functions in copper uptake and cuproptosis. Cell Metab. 36, 2118\u20132129.e6 (2024).","DOI":"10.1016\/j.cmet.2024.07.009"},{"key":"2192_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon, M. B. et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J. Biol. Chem. 299, 105046 (2023).","journal-title":"J. Biol. Chem."},{"key":"2192_CR299","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin, C. H. et al. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem. Sci. 49, 729\u2013744 (2024).","journal-title":"Trends Biochem. Sci."},{"key":"2192_CR300","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","volume":"42","author":"EA Rowland","year":"2018","unstructured":"Rowland, E. A., Snowden, C. K. & Cristea, I. M. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr. Opin. Chem. Biol. 42, 76\u201385 (2018).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2192_CR301","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson, A. & DeBerardinis, R. J. Lipoic acid metabolism and mitochondrial redox regulation. J. Biol. Chem. 293, 7522\u20137530 (2018).","journal-title":"J. Biol. Chem."},{"key":"2192_CR302","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1126\/science.aba8740","volume":"369","author":"N Attar","year":"2020","unstructured":"Attar, N. et al. The histone H3-H4 tetramer is a copper reductase enzyme. Science 369, 59\u201364 (2020).","journal-title":"Science"},{"key":"2192_CR303","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/jnc.15961","volume":"167","author":"JR Gale","year":"2023","unstructured":"Gale, J. R. et al. Copper induces neuron-sparing, ferredoxin 1-independent astrocyte toxicity mediated by oxidative stress. J. Neurochem 167, 277\u2013295 (2023).","journal-title":"J. Neurochem"},{"key":"2192_CR304","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216722120","volume":"120","author":"M Zulkifli","year":"2023","unstructured":"Zulkifli, M. et al. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. Proc. Natl. Acad. Sci. USA 120, e2216722120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR305","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1038\/s41388-019-0915-2","volume":"38","author":"Z Skrott","year":"2019","unstructured":"Skrott, Z. et al. Disulfiram\u2019s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase. Oncogene 38, 6711\u20136722 (2019).","journal-title":"Oncogene"},{"key":"2192_CR306","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu, Y. & Gu, W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin. Cancer Biol. 85, 4\u201332 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2192_CR307","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110926","volume":"392","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells. Chem. Biol. Interact. 392, 110926 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"2192_CR308","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phrs.2018.03.015","volume":"131","author":"AS Gomes","year":"2018","unstructured":"Gomes, A. S., Ramos, H., Soares, J. & Saraiva, L. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharm. Res 131, 75\u201386 (2018).","journal-title":"Pharm. Res"},{"key":"2192_CR309","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","volume":"30","author":"C Xiong","year":"2023","unstructured":"Xiong, C., Ling, H., Hao, Q. & Zhou, X. Cuproptosis: p53-regulated metabolic cell death? Cell Death Differ. 30, 876\u2013884 (2023).","journal-title":"Cell Death Differ."},{"key":"2192_CR310","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncb2172","volume":"13","author":"P Jiang","year":"2011","unstructured":"Jiang, P. et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 13, 310\u2013316 (2011).","journal-title":"Nat. Cell Biol."},{"key":"2192_CR311","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature11776","volume":"493","author":"P Jiang","year":"2013","unstructured":"Jiang, P. et al. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493, 689\u2013693 (2013).","journal-title":"Nature"},{"key":"2192_CR312","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed. Pharmacother. 159, 114301 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2192_CR313","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"MD Kornberg","year":"2018","unstructured":"Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449\u2013453 (2018).","journal-title":"Science"},{"key":"2192_CR314","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 14, 733 (2023).","journal-title":"Cell Death Dis."},{"key":"2192_CR315","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.7150\/thno.41648","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics 10, 8721\u20138743 (2020).","journal-title":"Theranostics"},{"key":"2192_CR316","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","volume":"53","author":"TB Steinbichler","year":"2018","unstructured":"Steinbichler, T. B. et al. Therapy resistance mediated by cancer stem cells. Semin. Cancer Biol. 53, 156\u2013167 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"2192_CR317","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/IJN.S441135","volume":"19","author":"C Peng","year":"2024","unstructured":"Peng, C. et al. TME-related biomimetic strategies against cancer. Int. J. Nanomed. 19, 109\u2013135 (2024).","journal-title":"Int. J. Nanomed."},{"key":"2192_CR318","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.7150\/thno.51777","volume":"11","author":"D Chen","year":"2021","unstructured":"Chen, D., Zhang, X., Li, Z. & Zhu, B. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics 11, 1016\u20131030 (2021).","journal-title":"Theranostics"},{"key":"2192_CR319","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.02.005","volume":"173","author":"T Eggert","year":"2017","unstructured":"Eggert, T. & Greten, T. F. Tumor regulation of the tissue environment in the liver. Pharm. Ther. 173, 47\u201357 (2017).","journal-title":"Pharm. Ther."},{"key":"2192_CR320","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41423-023-01086-x","volume":"20","author":"MM Hu","year":"2023","unstructured":"Hu, M. M. & Shu, H. B. Mitochondrial DNA-triggered innate immune response: mechanisms and diseases. Cell Mol. Immunol. 20, 1403\u20131412 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"2192_CR321","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122512","volume":"307","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling. Biomaterials 307, 122512 (2024).","journal-title":"Biomaterials"},{"key":"2192_CR322","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mattod.2023.06.024","volume":"68","author":"X-K Jin","year":"2023","unstructured":"Jin, X.-K. et al. Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal cancer. Mater. Today 68, 108\u2013124 (2023).","journal-title":"Mater. Today"},{"key":"2192_CR323","doi-asserted-by":"crossref","unstructured":"Chen, R., Zou, J., Kang, R. & Tang, D. The redox protein HMGB1 in cell death and cancer. Antioxid Redox Signal, (2023).","DOI":"10.1089\/ars.2023.0007"},{"key":"2192_CR324","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308241","volume":"36","author":"L Qiao","year":"2024","unstructured":"Qiao, L. et al. Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv. Mater. 36, e2308241 (2024).","journal-title":"Adv. Mater."},{"key":"2192_CR325","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101911","volume":"51","author":"Q-X Huang","year":"2023","unstructured":"Huang, Q.-X. et al. Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today 51, 101911 (2023).","journal-title":"Nano Today"},{"key":"2192_CR326","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo, B. et al. Cuproptosis Induced by ROS-responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv. Mater. 35, e2212267 (2023).","journal-title":"Adv. Mater."},{"key":"2192_CR327","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309984","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. Elesclomol-loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv. Sci. 11, e2309984 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR328","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.996307","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. HMGB1 is a mediator of cuproptosis-related sterile inflammation. Front. Cell Dev. Biol. 10, 996307 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"2192_CR329","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13578-022-00948-7","volume":"12","author":"A Jiang","year":"2022","unstructured":"Jiang, A. et al. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell Biosci. 12, 209 (2022).","journal-title":"Cell Biosci."},{"key":"2192_CR330","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1039\/D3TB02886K","volume":"12","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. A mitochondria-targeted anticancer copper dithiocarbamate amplifies immunogenic cuproptosis and macrophage polarization. J. Mater. Chem. B 12, 2006\u20132014 (2024).","journal-title":"J. Mater. Chem. B"},{"key":"2192_CR331","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1021\/jacs.3c14247","volume":"146","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Enzyme core spherical nucleic acid that enables enhanced cuproptosis and antitumor immune response through alleviating tumor hypoxia. J. Am. Chem. Soc. 146, 13805\u201313816 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2192_CR332","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303694","volume":"10","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. Mild-photothermal effect induced high efficiency ferroptosis-boosted-cuproptosis based on Cu(2)O@Mn(3)Cu(3)O(8) Nanozyme. Adv. Sci. 10, e2303694 (2023).","journal-title":"Adv. Sci."},{"key":"2192_CR333","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1021\/acsnano.3c13225","volume":"18","author":"J Bao","year":"2024","unstructured":"Bao, J. et al. Coordination self-assembled AuTPyP-Cu metal-organic framework nanosheets with pH\/ultrasound dual-responsiveness for synergistically triggering cuproptosis-augmented chemotherapy. ACS Nano 18, 9100\u20139113 (2024).","journal-title":"ACS Nano"},{"key":"2192_CR334","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1021\/jacs.3c08622","volume":"146","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity. J. Am. Chem. Soc. 146, 3675\u20133688 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2192_CR335","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202306263","volume":"20","author":"R Li","year":"2024","unstructured":"Li, R. et al. Self-cascade nanozyme reactor as a cuproptosis inducer synergistic inhibition of cellular respiration boosting radioimmunotherapy. Small 20, e2306263 (2024).","journal-title":"Small"},{"key":"2192_CR336","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcis.2023.03.065","volume":"641","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. In-situ fabrication of novel Au nanoclusters-Cu(2+)@sodium alginate\/hyaluronic acid nanohybrid gels for cuproptosis enhanced photothermal\/photodynamic\/chemodynamic therapy via tumor microenvironment regulation. J. Colloid Interface Sci. 641, 215\u2013228 (2023).","journal-title":"J. Colloid Interface Sci."},{"key":"2192_CR337","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Biomimetic nano-regulator that induces cuproptosis and lactate-depletion mediated ROS storm for metalloimmunotherapy of clear cell renal cell carcinoma. Adv. Healthc. Mater., e2400204, (2024).","DOI":"10.1002\/adhm.202400204"},{"key":"2192_CR338","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309388","volume":"11","author":"F Hu","year":"2024","unstructured":"Hu, F. et al. Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy. Adv. Sci. 11, e2309388 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR339","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Y Qin","year":"2023","unstructured":"Qin, Y. et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol. Cancer 22, 59 (2023).","journal-title":"Mol. Cancer"},{"key":"2192_CR340","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981764","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. Front. Immunol. 13, 981764 (2022).","journal-title":"Front. Immunol."},{"key":"2192_CR341","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.923737","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front. Genet. 13, 923737 (2022).","journal-title":"Front. Genet."},{"key":"2192_CR342","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999823","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Front. Immunol. 13, 999823 (2022).","journal-title":"Front. Immunol."},{"key":"2192_CR343","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41435-023-00211-0","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC. Genes Immun. 24, 171\u2013182 (2023).","journal-title":"Genes Immun."},{"key":"2192_CR344","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.963639","volume":"10","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. Pan-cancer integrated bioinformatics analysis reveals cuproptosis-related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Front. Mol. Biosci. 10, 963639 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"2192_CR345","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","volume":"289","author":"MS Patel","year":"2014","unstructured":"Patel, M. S., Nemeria, N. S., Furey, W. & Jordan, F. The pyruvate dehydrogenase complexes: structure-based function and regulation. J. Biol. Chem. 289, 16615\u201316623 (2014).","journal-title":"J. Biol. Chem."},{"key":"2192_CR346","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.plaphy.2011.07.001","volume":"49","author":"J Casteel","year":"2011","unstructured":"Casteel, J., Miernyk, J. A. & Thelen, J. J. Mapping the lipoylation site of Arabidopsis thaliana plastidial dihydrolipoamide S-acetyltransferase using mass spectrometry and site-directed mutagenesis. Plant Physiol. Biochem. 49, 1355\u20131361 (2011).","journal-title":"Plant Physiol. Biochem."},{"key":"2192_CR347","first-page":"1140","volume":"7","author":"WQ Goh","year":"2015","unstructured":"Goh, W. Q. et al. DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy. Am. J. Transl. Res. 7, 1140\u20131151 (2015).","journal-title":"Am. J. Transl. Res."},{"key":"2192_CR348","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13046-022-02437-8","volume":"41","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming. J. Exp. Clin. Cancer Res. 41, 229 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2192_CR349","doi-asserted-by":"publisher","first-page":"12314","DOI":"10.18632\/aging.205181","volume":"15","author":"S Huang","year":"2023","unstructured":"Huang, S. et al. Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging 15, 12314\u201312329 (2023).","journal-title":"Aging"},{"key":"2192_CR350","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43835-y","volume":"13","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Sci. Rep. 13, 17295 (2023).","journal-title":"Sci. Rep."},{"key":"2192_CR351","doi-asserted-by":"crossref","unstructured":"Bian, Z., Fan, R. & Xie, L. A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma. Genes 13, (2022).","DOI":"10.3390\/genes13050851"},{"key":"2192_CR352","doi-asserted-by":"publisher","first-page":"1117164","DOI":"10.3389\/fonc.2023.1117164","volume":"13","author":"Q Zhao","year":"2023","unstructured":"Zhao, Q. & Qi, T. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression. Front. Oncol. 13, 1117164 (2023).","journal-title":"Front. Oncol."},{"key":"2192_CR353","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952129","volume":"12","author":"Y Cai","year":"2022","unstructured":"Cai, Y. et al. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Front. Oncol. 12, 952129 (2022).","journal-title":"Front. Oncol."},{"key":"2192_CR354","doi-asserted-by":"publisher","first-page":"984158","DOI":"10.3389\/fgene.2022.984158","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu, W., Dong, J., Lv, Y. & Chang, D. Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment. Front. Genet. 13, 984158 (2022).","journal-title":"Front. Genet."},{"key":"2192_CR355","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","volume":"10","author":"G Samimi","year":"2004","unstructured":"Samimi, G. et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 10, 4661\u20134669 (2004).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR356","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12568","volume":"52","author":"Z Yu","year":"2019","unstructured":"Yu, Z. et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 52, e12568 (2019).","journal-title":"Cell Prolif."},{"key":"2192_CR357","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110943","volume":"393","author":"Z Qiu","year":"2024","unstructured":"Qiu, Z. et al. The copper transporter, SLC31A1, transcriptionally activated by ELF3, imbalances copper homeostasis to exacerbate cisplatin-induced acute kidney injury through mitochondrial dysfunction. Chem. Biol. Interact. 393, 110943 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"2192_CR358","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10534-006-9074-3","volume":"20","author":"MY Bartee","year":"2007","unstructured":"Bartee, M. Y. & Lutsenko, S. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level. Biometals 20, 627\u2013637 (2007).","journal-title":"Biometals"},{"key":"2192_CR359","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105924","volume":"148","author":"B Chen","year":"2022","unstructured":"Chen, B. et al. A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma. Comput. Biol. Med 148, 105924 (2022).","journal-title":"Comput. Biol. Med"},{"key":"2192_CR360","first-page":"733","volume":"15","author":"Y Yun","year":"2022","unstructured":"Yun, Y., Wang, Y., Yang, E. & Jing, X. Cuproptosis-related gene - SLC31A1, FDX1 and ATP7B - polymorphisms are associated with risk of lung cancer. Pharmgenom. Pers. Med. 15, 733\u2013742 (2022).","journal-title":"Pharmgenom. Pers. Med."},{"key":"2192_CR361","first-page":"3561","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X., Ma, Z. & Mei, L. Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer. Am. J. Cancer Res. 12, 3561\u20133580 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"2192_CR362","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04894-6","volume":"23","author":"L Li","year":"2022","unstructured":"Li, L., Li, L. & Sun, Q. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. BMC Bioinforma. 23, 350 (2022).","journal-title":"BMC Bioinforma."},{"key":"2192_CR363","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922780","volume":"13","author":"S Sha","year":"2022","unstructured":"Sha, S. et al. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer. Front. Immunol. 13, 922780 (2022).","journal-title":"Front. Immunol."},{"key":"2192_CR364","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985484","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer. Front. Oncol. 12, 985484 (2022).","journal-title":"Front. Oncol."},{"key":"2192_CR365","first-page":"6026","volume":"15","author":"J Mi","year":"2023","unstructured":"Mi, J. et al. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. Am. J. Transl. Res. 15, 6026\u20136041 (2023).","journal-title":"Am. J. Transl. Res."},{"key":"2192_CR366","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10142-023-01210-0","volume":"23","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. Funct. Integr. Genom. 23, 279 (2023).","journal-title":"Funct. Integr. Genom."},{"key":"2192_CR367","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI110176","volume":"67","author":"KF Sheu","year":"1981","unstructured":"Sheu, K. F., Hu, C. W. & Utter, M. F. Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J. Clin. Investig. 67, 1463\u20131471 (1981).","journal-title":"J. Clin. Investig."},{"key":"2192_CR368","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1007\/s10238-023-01108-y","volume":"23","author":"J Ma","year":"2023","unstructured":"Ma, J., Gong, B. & Zhao, Q. Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives. Clin. Exp. Med. 23, 4997\u20135014 (2023).","journal-title":"Clin. Exp. Med."},{"key":"2192_CR369","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.947372","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng, L. et al. Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer. Front. Pharm. 13, 947372 (2022).","journal-title":"Front. Pharm."},{"key":"2192_CR370","volume":"102","author":"D Zhang","year":"2023","unstructured":"Zhang, D., Wang, T., Zhou, Y. & Zhang, X. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors. Medicines 102, e33468 (2023).","journal-title":"Medicines"},{"key":"2192_CR371","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1188725","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients. Front. Pharm. 14, 1188725 (2023).","journal-title":"Front. Pharm."},{"key":"2192_CR372","doi-asserted-by":"publisher","first-page":"1036408","DOI":"10.3389\/fgene.2022.1036408","volume":"13","author":"K Fan","year":"2022","unstructured":"Fan, K., Dong, Y., Li, T. & Li, Y. Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma. Front. Genet. 13, 1036408 (2022).","journal-title":"Front. Genet."},{"key":"2192_CR373","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100577","volume":"19","author":"C Yu","year":"2023","unstructured":"Yu, C. et al. A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy. Mater. Today Biol. 19, 100577 (2023).","journal-title":"Mater. Today Biol."},{"key":"2192_CR374","doi-asserted-by":"crossref","unstructured":"Gu, S. et al. Expression and functional analysis of the metallothionein and metal-responsive transcription factor 1 in Phascolosoma esculenta under Zn Stress. Int. J. Mol. Sci. 25, (2024).","DOI":"10.3390\/ijms25137368"},{"key":"2192_CR375","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1037941","volume":"9","author":"C McCann","year":"2022","unstructured":"McCann, C. et al. The mitochondrial Cu(+) transporter PiC2 (SLC25A3) is a target of MTF1 and contributes to the development of skeletal muscle in vitro. Front. Mol. Biosci. 9, 1037941 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"2192_CR376","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04557-9","volume":"604","author":"A Solmonson","year":"2022","unstructured":"Solmonson, A. et al. Compartmentalized metabolism supports midgestation mammalian development. Nature 604, 349\u2013353 (2022).","journal-title":"Nature"},{"key":"2192_CR377","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03630-1","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan, C. et al. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. J. Transl. Med. 20, 452 (2022).","journal-title":"J. Transl. Med."},{"key":"2192_CR378","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.930041","volume":"13","author":"H Lv","year":"2022","unstructured":"Lv, H. et al. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma. Front Pharm. 13, 930041 (2022).","journal-title":"Front Pharm."},{"key":"2192_CR379","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404971","volume":"36","author":"S Lu","year":"2024","unstructured":"Lu, S., Li, Y. & Yu, Y. Glutathione-scavenging celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy. Adv. Mater. 36, e2404971 (2024).","journal-title":"Adv. Mater."},{"key":"2192_CR380","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403253","volume":"36","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. A vacancy-engineering ferroelectric nanomedicine for cuproptosis\/apoptosis co-activated immunotherapy. Adv. Mater. 36, e2403253 (2024).","journal-title":"Adv. Mater."},{"key":"2192_CR381","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202405639","volume":"63","author":"N Yu","year":"2024","unstructured":"Yu, N. et al. Sono-triggered cascade lactate depletion by semiconducting polymer nanoreactors for cuproptosis-immunotherapy of pancreatic cancer. Angew. Chem. Int Ed. Engl. 63, e202405639 (2024).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"2192_CR382","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202405937","volume":"63","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Bioorthogonal Cu single-atom nanozyme for synergistic nanocatalytic therapy, photothermal therapy, cuproptosis and immunotherapy. Angew. Chem. Int Ed. Engl. 63, e202405937 (2024).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"2192_CR383","doi-asserted-by":"publisher","first-page":"12386","DOI":"10.1021\/acsnano.4c01518","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Metal-organic framework-based nanovaccine for relieving immunosuppressive tumors via hindering efferocytosis of macrophages and promoting pyroptosis and cuproptosis of cancer cells. ACS Nano 18, 12386\u201312400 (2024).","journal-title":"ACS Nano"},{"key":"2192_CR384","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.apsb.2024.01.017","volume":"14","author":"C Yan","year":"2024","unstructured":"Yan, C. et al. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy. Acta Pharm. Sin. B 14, 2281\u20132297 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2192_CR385","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, J., Weichselbaum, R. R. & Lin, W. Mitochondria-targeted multifunctional nanoparticles combine cuproptosis and programmed cell death-1 downregulation for cancer immunotherapy. Adv. Sci., e2403520, (2024).","DOI":"10.1002\/advs.202403520"},{"key":"2192_CR386","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401047","volume":"11","author":"H Wu","year":"2024","unstructured":"Wu, H. et al. A self-amplifying ROS-responsive nanoplatform for simultaneous cuproptosis and cancer immunotherapy. Adv. Sci. 11, e2401047 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR387","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv. Sci. 11, e2310309 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR388","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122455","volume":"305","author":"Y Dai","year":"2024","unstructured":"Dai, Y. et al. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence\/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy. Biomaterials 305, 122455 (2024).","journal-title":"Biomaterials"},{"key":"2192_CR389","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/med.20174","volume":"30","author":"F Tisato","year":"2010","unstructured":"Tisato, F. et al. Copper in diseases and treatments, and copper-based anticancer strategies. Med. Res. Rev. 30, 708\u2013749 (2010).","journal-title":"Med. Res. Rev."},{"key":"2192_CR390","doi-asserted-by":"crossref","unstructured":"Baldari, S., Di Rocco, G. & Toietta, G. Current biomedical use of copper chelation therapy. Int. J. Mol. Sci. 21, (2020).","DOI":"10.3390\/ijms21031069"},{"key":"2192_CR391","doi-asserted-by":"publisher","DOI":"10.1038\/srep14296","volume":"5","author":"KK Kim","year":"2015","unstructured":"Kim, K. K. et al. Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1\u03b1 in cancer cells. Sci. Rep. 5, 14296 (2015).","journal-title":"Sci. Rep."},{"key":"2192_CR392","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-16-1190","volume":"77","author":"DC Brady","year":"2017","unstructured":"Brady, D. C., Crowe, M. S., Greenberg, D. N. & Counter, C. M. Copper chelation inhibits BRAF(V600E)-driven melanomagenesis and counters resistance to BRAF(V600E) and MEK1\/2 Inhibitors. Cancer Res. 77, 6240\u20136252 (2017).","journal-title":"Cancer Res."},{"key":"2192_CR393","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1158\/0008-5472.CAN-19-1784","volume":"80","author":"YJ Kim","year":"2020","unstructured":"Kim, Y. J. et al. Inhibition of BCL2 family members increases the efficacy of copper chelation in BRAF(V600E)-driven melanoma. Cancer Res. 80, 1387\u20131400 (2020).","journal-title":"Cancer Res."},{"key":"2192_CR394","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-17-3705","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Copper chelation as targeted therapy in a mouse model of oncogenic BRAF-driven papillary thyroid cancer. Clin. Cancer Res. 24, 4271\u20134281 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR395","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/mmt-2015-0005","volume":"3","author":"S Sammons","year":"2016","unstructured":"Sammons, S., Brady, D., Vahdat, L. & Salama, A. K. Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAF(V600) mutated melanoma. Melanoma Manag. 3, 207\u2013216 (2016).","journal-title":"Melanoma Manag."},{"key":"2192_CR396","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-20-3177","volume":"26","author":"N Chan","year":"2020","unstructured":"Chan, N. et al. Correction: influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases. Clin. Cancer Res. 26, 5051 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR397","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.athoracsur.2008.03.016","volume":"86","author":"HI Pass","year":"2008","unstructured":"Pass, H. I. et al. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. Ann. Thorac. Surg. 86, 383\u2013389 (2008).","journal-title":"Ann. Thorac. Surg."},{"key":"2192_CR398","first-page":"617","volume":"2","author":"Q Pan","year":"2003","unstructured":"Pan, Q. et al. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Mol. Cancer Ther. 2, 617\u2013622 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"2192_CR399","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/sj.neo.7900218","volume":"4","author":"MK Khan","year":"2002","unstructured":"Khan, M. K. et al. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia 4, 164\u2013170 (2002).","journal-title":"Neoplasia"},{"key":"2192_CR400","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ygyno.2011.03.035","volume":"122","author":"KK Kim","year":"2011","unstructured":"Kim, K. K. et al. Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines. Gynecol. Oncol. 122, 183\u2013189 (2011).","journal-title":"Gynecol. Oncol."},{"key":"2192_CR401","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-147","volume":"12","author":"KK Kim","year":"2012","unstructured":"Kim, K. K. et al. Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C. BMC Cancer 12, 147 (2012).","journal-title":"BMC Cancer"},{"key":"2192_CR402","first-page":"989","volume":"52","author":"A Morisawa","year":"2018","unstructured":"Morisawa, A. et al. Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma. Int. J. Oncol. 52, 989\u2013999 (2018).","journal-title":"Int. J. Oncol."},{"key":"2192_CR403","first-page":"2611","volume":"42","author":"S Ryumon","year":"2019","unstructured":"Ryumon, S. et al. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma. Oncol. Rep. 42, 2611\u20132621 (2019).","journal-title":"Oncol. Rep."},{"key":"2192_CR404","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10637-008-9165-9","volume":"27","author":"EM Gartner","year":"2009","unstructured":"Gartner, E. M. et al. A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer. Investig. New. Drugs 27, 159\u2013165 (2009).","journal-title":"Investig. New. Drugs"},{"key":"2192_CR405","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/annonc\/mds654","volume":"24","author":"S Jain","year":"2013","unstructured":"Jain, S. et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Ann. Oncol. 24, 1491\u20131498 (2013).","journal-title":"Ann. Oncol."},{"key":"2192_CR406","first-page":"1666","volume":"9","author":"BG Redman","year":"2003","unstructured":"Redman, B. G. et al. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin. Cancer Res 9, 1666\u20131672 (2003).","journal-title":"Clin. Cancer Res"},{"key":"2192_CR407","doi-asserted-by":"publisher","first-page":"111865","DOI":"10.1016\/j.jinorgbio.2022.111865","volume":"233","author":"Y Li","year":"2022","unstructured":"Li, Y., Fang, M., Xu, Z. & Li, X. Tetrathiomolybdate as an old drug in a new use: as a chemotherapeutic sensitizer for non-small cell lung cancer. J. Inorg. Biochem. 233, 111865 (2022).","journal-title":"J. Inorg. Biochem."},{"key":"2192_CR408","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000106066","volume":"71","author":"NL Henry","year":"2006","unstructured":"Henry, N. L. et al. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer. Oncology 71, 168\u2013175 (2006).","journal-title":"Oncology"},{"key":"2192_CR409","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-06-0171","volume":"12","author":"JC Juarez","year":"2006","unstructured":"Juarez, J. C. et al. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin. Cancer Res. 12, 4974\u20134982 (2006).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR410","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2015.8","volume":"2","author":"JY Yoo","year":"2015","unstructured":"Yoo, J. Y. et al. ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma. Mol. Ther. Oncol. 2, 15008 (2015).","journal-title":"Mol. Ther. Oncol."},{"key":"2192_CR411","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1158\/1078-0432.CCR-08-0315","volume":"14","author":"SA Lowndes","year":"2008","unstructured":"Lowndes, S. A. et al. Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors. Clin. Cancer Res. 14, 7526\u20137534 (2008).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR412","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.urolonc.2011.04.009","volume":"31","author":"J Lin","year":"2013","unstructured":"Lin, J. et al. A non-comparative randomized phase II study of 2 doses of ATN-224, a copper\/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-na\u00efve prostate cancer. Urol. Oncol. 31, 581\u2013588 (2013).","journal-title":"Urol. Oncol."},{"key":"2192_CR413","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(82)90456-1","volume":"2","author":"DM Danks","year":"1982","unstructured":"Danks, D. M. Penicillamine in Wilson\u2019s disease. Lancet 2, 435\u2013436 (1982).","journal-title":"Lancet"},{"key":"2192_CR414","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.ajpath.2013.06.026","volume":"183","author":"T Mammoto","year":"2013","unstructured":"Mammoto, T. et al. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am. J. Pathol. 183, 1293\u20131305 (2013).","journal-title":"Am. J. Pathol."},{"key":"2192_CR415","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bcp.2015.03.006","volume":"95","author":"SJ Chen","year":"2015","unstructured":"Chen, S. J. et al. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo. Biochem Pharm. 95, 28\u201337 (2015).","journal-title":"Biochem Pharm."},{"key":"2192_CR416","doi-asserted-by":"crossref","unstructured":"Lai, Y. H., Kuo, C., Kuo, M. T. & Chen, H. H. W. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis. Int J Mol Sci. 19, (2018).","DOI":"10.3390\/ijms19051486"},{"key":"2192_CR417","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.freeradbiomed.2017.04.001","volume":"108","author":"SJ Sciegienka","year":"2017","unstructured":"Sciegienka, S. J. et al. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H(2)O(2)-mediated oxidative stress. Free Radic. Biol. Med. 108, 354\u2013361 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR418","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1215\/S1152851704000869","volume":"7","author":"S Brem","year":"2005","unstructured":"Brem, S. et al. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol. 7, 246\u2013253 (2005).","journal-title":"Neuro Oncol."},{"key":"2192_CR419","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-2008-1040842","volume":"19","author":"GJ Brewer","year":"1999","unstructured":"Brewer, G. J., Fink, J. K. & Hedera, P. Diagnosis and treatment of Wilson\u2019s disease. Semin. Neurol. 19, 261\u2013270 (1999).","journal-title":"Semin. Neurol."},{"key":"2192_CR420","doi-asserted-by":"crossref","unstructured":"Lopez, J., Ramchandani, D. & Vahdat, L. Copper depletion as a therapeutic strategy in cancer. Met. Ions Life Sci. 19, (2019).","DOI":"10.1515\/9783110527872-012"},{"key":"2192_CR421","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S2468-1253(22)00270-9","volume":"7","author":"ML Schilsky","year":"2022","unstructured":"Schilsky, M. L. et al. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. Lancet Gastroenterol. Hepatol. 7, 1092\u20131102 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2192_CR422","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/ijc.1537","volume":"94","author":"J Yoshii","year":"2001","unstructured":"Yoshii, J. et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int. J. Cancer 94, 768\u2013773 (2001).","journal-title":"Int. J. Cancer"},{"key":"2192_CR423","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ijc.10740","volume":"102","author":"M Moriguchi","year":"2002","unstructured":"Moriguchi, M. et al. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. Int. J. Cancer 102, 445\u2013452 (2002).","journal-title":"Int. J. Cancer"},{"key":"2192_CR424","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1158\/1535-7163.MCT-11-0864","volume":"11","author":"S Fu","year":"2012","unstructured":"Fu, S. et al. Overcoming platinum resistance through the use of a copper-lowering agent. Mol. Cancer Ther. 11, 1221\u20131225 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"2192_CR425","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fonc.2019.00437","volume":"9","author":"YF Huang","year":"2019","unstructured":"Huang, Y. F. et al. A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial ovarian, tubal, and peritoneal cancer within 12 months after platinum-based chemotherapy. Front. Oncol. 9, 437 (2019).","journal-title":"Front. Oncol."},{"key":"2192_CR426","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10637-013-0051-8","volume":"32","author":"S Fu","year":"2014","unstructured":"Fu, S. et al. Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies. Investig. New Drugs 32, 465\u2013472 (2014).","journal-title":"Investig. New Drugs"},{"key":"2192_CR427","first-page":"3651","volume":"32","author":"VK Yellepeddi","year":"2012","unstructured":"Yellepeddi, V. K., Vangara, K. K., Kumar, A. & Palakurthi, S. Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells. Anticancer Res. 32, 3651\u20133658 (2012).","journal-title":"Anticancer Res."},{"key":"2192_CR428","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan, D. et al. Nanomedicine in cancer therapy. Signal Transduct. Target Ther. 8, 293 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2192_CR429","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387\u20136392 (1986).","journal-title":"Cancer Res."},{"key":"2192_CR430","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751\u2013760 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"2192_CR431","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrd4333","volume":"13","author":"VP Torchilin","year":"2014","unstructured":"Torchilin, V. P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13, 813\u2013827 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2192_CR432","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z., Ukidve, A., Kim, J. & Mitragotri, S. Targeting strategies for tissue-specific drug delivery. Cell 181, 151\u2013167 (2020).","journal-title":"Cell"},{"key":"2192_CR433","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121760","volume":"289","author":"M Ismail","year":"2022","unstructured":"Ismail, M. et al. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials 289, 121760 (2022).","journal-title":"Biomaterials"},{"key":"2192_CR434","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","volume":"39","author":"L Cui","year":"2021","unstructured":"Cui, L. et al. Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat. Biotechnol. 39, 357\u2013367 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2192_CR435","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biomaterials.2019.01.007","volume":"195","author":"P Zhou","year":"2019","unstructured":"Zhou, P. et al. Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer. Biomaterials 195, 86\u201399 (2019).","journal-title":"Biomaterials"},{"key":"2192_CR436","volume":"500","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. Responsively aggregatable nanochelator-mediated antiangiogenesis to enhance interventional therapies for liver cancer. Chem. Eng. J. Adv. 500, 156925 (2024).","journal-title":"Chem. Eng. J. Adv."},{"key":"2192_CR437","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1021\/acs.nanolett.9b02691","volume":"19","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Responsively aggregatable Sub-6\u2009nm nanochelators induce simultaneous antiangiogenesis and vascular obstruction for enhanced tumor vasculature targeted therapy. Nano Lett. 19, 7750\u20137759 (2019).","journal-title":"Nano Lett."},{"key":"2192_CR438","volume":"422","author":"V Oliveri","year":"2020","unstructured":"Oliveri, V. Biomedical applications of copper ionophores. Chem. Commun. 422, 213474 (2020).","journal-title":"Chem. Commun."},{"key":"2192_CR439","doi-asserted-by":"publisher","first-page":"841814","DOI":"10.3389\/fmolb.2022.841814","volume":"9","author":"V Oliveri","year":"2022","unstructured":"Oliveri, V. Selective targeting of cancer cells by copper ionophores: an overview. Front. Mol. Biosci. 9, 841814 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"2192_CR440","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1016\/j.bmcl.2013.07.032","volume":"23","author":"S Chen","year":"2013","unstructured":"Chen, S. et al. Syntheses and antitumor activities of N'1,N'3-dialkyl-N'1,N'3-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol. Bioorg. Med. Chem. Lett. 23, 5070\u20135076 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2192_CR441","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1200\/JCO.2008.17.1579","volume":"27","author":"S O\u2019Day","year":"2009","unstructured":"O\u2019Day, S. et al. Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. J. Clin. Oncol. 27, 5452\u20135458 (2009).","journal-title":"J. Clin. Oncol."},{"key":"2192_CR442","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J. Exp. Clin. Cancer Res. 42, 142 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2192_CR443","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ygyno.2018.10.001","volume":"151","author":"BJ Monk","year":"2018","unstructured":"Monk, B. J. et al. A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: an NRG oncology\/gynecologic oncology group study. Gynecol. Oncol. 151, 422\u2013427 (2018).","journal-title":"Gynecol. Oncol."},{"key":"2192_CR444","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1078-0432.CCR-06-0964","volume":"13","author":"A Berkenblit","year":"2007","unstructured":"Berkenblit, A. et al. Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors. Clin. Cancer Res. 13, 584\u2013590 (2007).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR445","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3109\/10428194.2016.1138293","volume":"57","author":"D Hedley","year":"2016","unstructured":"Hedley, D. et al. A phase I study of elesclomol sodium in patients with acute myeloid leukemia. Leuk. Lymphoma 57, 2437\u20132440 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"2192_CR446","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","volume":"31","author":"SJ O\u2019Day","year":"2013","unstructured":"O\u2019Day, S. J. et al. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J. Clin. Oncol. 31, 1211\u20131218 (2013).","journal-title":"J. Clin. Oncol."},{"key":"2192_CR447","doi-asserted-by":"publisher","first-page":"121335","DOI":"10.1016\/j.biomaterials.2021.121335","volume":"281","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens. Biomaterials 281, 121335 (2022).","journal-title":"Biomaterials"},{"key":"2192_CR448","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","volume":"25","author":"H Li","year":"2020","unstructured":"Li, H. et al. The combination of disulfiram and copper for cancer treatment. Drug Discov. Today 25, 1099\u20131108 (2020).","journal-title":"Drug Discov. Today"},{"key":"2192_CR449","doi-asserted-by":"publisher","first-page":"186","DOI":"10.31083\/j.fbl2808186","volume":"28","author":"M Chu","year":"2023","unstructured":"Chu, M. et al. Disulfiram\/copper induce ferroptosis in triple-negative breast cancer cell line MDA-MB-231.Front. Biosci. (Landmark Ed.) 28, 186 (2023).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"2192_CR450","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35619-6","volume":"9","author":"L Wu","year":"2019","unstructured":"Wu, L. et al. Disulfiram and BKM120 in combination with chemotherapy impede tumor progression and delay tumor recurrence in tumor initiating cell-rich TNBC. Sci. Rep. 9, 236 (2019).","journal-title":"Sci. Rep."},{"key":"2192_CR451","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109371","volume":"118","author":"F Guo","year":"2019","unstructured":"Guo, F. et al. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by disulfiram and copper treatment through ALDH and ROS modulation. Biomed. Pharmacother. 118, 109371 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2192_CR452","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2021.02.002","volume":"505","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Lett. 505, 37\u201348 (2021).","journal-title":"Cancer Lett."},{"key":"2192_CR453","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2174\/0929867324666171023161121","volume":"25","author":"M Viola-Rhenals","year":"2018","unstructured":"Viola-Rhenals, M. et al. Recent advances in antabuse (Disulfiram): the importance of its metal-binding ability to its anticancer activity. Curr. Med. Chem. 25, 506\u2013524 (2018).","journal-title":"Curr. Med. Chem."},{"key":"2192_CR454","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.18632\/oncotarget.707","volume":"3","author":"P Hothi","year":"2012","unstructured":"Hothi, P. et al. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells. Oncotarget 3, 1124\u20131136 (2012).","journal-title":"Oncotarget"},{"key":"2192_CR455","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.18632\/oncotarget.604","volume":"3","author":"J Triscott","year":"2012","unstructured":"Triscott, J. et al. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide. Oncotarget 3, 1112\u20131123 (2012).","journal-title":"Oncotarget"},{"key":"2192_CR456","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","volume":"20","author":"H Nechushtan","year":"2015","unstructured":"Nechushtan, H. et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist 20, 366\u2013367 (2015).","journal-title":"Oncologist"},{"key":"2192_CR457","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10637-022-01271-1","volume":"40","author":"M Mego","year":"2022","unstructured":"Mego, M. et al. Phase II study of disulfiram and cisplatin in refractory germ cell tumors. The GCT-SK-006 phase II trial. Investig. New Drugs 40, 1080\u20131086 (2022).","journal-title":"Investig. New Drugs"},{"key":"2192_CR458","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08242-4","volume":"21","author":"KC Kelley","year":"2021","unstructured":"Kelley, K. C. et al. A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker. BMC Cancer 21, 510 (2021).","journal-title":"BMC Cancer"},{"key":"2192_CR459","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.4149","volume":"6","author":"K Werlenius","year":"2023","unstructured":"Werlenius, K. et al. Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: a randomized clinical trial. JAMA Netw. Open 6, e234149 (2023).","journal-title":"JAMA Netw. Open"},{"key":"2192_CR460","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10495-022-01737-w","volume":"27","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. A novel 8-hydroxyquinoline derivative induces breast cancer cell death through paraptosis and apoptosis. Apoptosis 27, 577\u2013589 (2022).","journal-title":"Apoptosis"},{"key":"2192_CR461","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20081421","volume":"417","author":"H Yu","year":"2009","unstructured":"Yu, H., Zhou, Y., Lind, S. E. & Ding, W. Q. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 417, 133\u2013139 (2009).","journal-title":"Biochem J."},{"key":"2192_CR462","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00775-009-0594-5","volume":"15","author":"S Zhai","year":"2010","unstructured":"Zhai, S. et al. Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells. J. Biol. Inorg. Chem. 15, 259\u2013269 (2010).","journal-title":"J. Biol. Inorg. Chem."},{"key":"2192_CR463","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00204-020-02894-0","volume":"95","author":"M Katsuyama","year":"2021","unstructured":"Katsuyama, M. et al. Clioquinol inhibits dopamine-\u03b2-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells. Arch. Toxicol. 95, 135\u2013148 (2021).","journal-title":"Arch. Toxicol."},{"key":"2192_CR464","doi-asserted-by":"publisher","first-page":"e2400652","DOI":"10.1002\/adhm.202400652","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu, J., Miao, Y. & Li, Y. Cuproptosis: advances in stimulus-responsive nanomaterials for cancer therapy. Adv. Health. Mater. 13, e2400652 (2024).","journal-title":"Adv. Health. Mater."},{"key":"2192_CR465","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.actbio.2023.04.003","volume":"164","author":"C Ni","year":"2023","unstructured":"Ni, C. et al. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy. Acta Biomater. 164, 474\u2013486 (2023).","journal-title":"Acta Biomater."},{"key":"2192_CR466","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204733","volume":"34","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv. Mater. 34, e2204733 (2022).","journal-title":"Adv. Mater."},{"key":"2192_CR467","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202213922","volume":"62","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy. Angew. Chem. Int. Ed. Engl. 62, e202213922 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2192_CR468","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123025","volume":"640","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism. Int. J. Pharm. 640, 123025 (2023).","journal-title":"Int. J. Pharm."},{"key":"2192_CR469","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1021\/acsnano.3c04903","volume":"17","author":"J Xia","year":"2023","unstructured":"Xia, J. et al. Copper-loaded nanoheterojunction enables superb orthotopic osteosarcoma therapy via oxidative stress and cell cuproptosis. ACS Nano 17, 21134\u201321152 (2023).","journal-title":"ACS Nano"},{"key":"2192_CR470","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402516","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy. Adv. Sci. 11, e2402516 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR471","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0039","volume":"28","author":"Y Luo","year":"2024","unstructured":"Luo, Y. et al. Copper(II)-based nano-regulator correlates cuproptosis burst and sequential immunogenic cell death for synergistic cancer immunotherapy. Biomater. Res. 28, 0039 (2024).","journal-title":"Biomater. Res."},{"key":"2192_CR472","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202311549","volume":"62","author":"H Ding","year":"2023","unstructured":"Ding, H. et al. Cu(2+) -anchored carbon nano-photocatalysts for visible water splitting to boost hydrogen cuproptosis. Angew. Chem. Int. Ed. Engl. 62, e202311549 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2192_CR473","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202308565","volume":"20","author":"J Chang","year":"2024","unstructured":"Chang, J. et al. Copper deposition in polydopamine nanostructure to promote cuproptosis by catalytically inhibiting copper exporters of tumor cells for cancer immunotherapy. Small 20, e2308565 (2024).","journal-title":"Small"},{"key":"2192_CR474","doi-asserted-by":"publisher","first-page":"23941","DOI":"10.1021\/acsnano.3c10588","volume":"18","author":"H Zu","year":"2024","unstructured":"Zu, H. et al. Tumor metabolism aiming Cu(2-x)S nanoagents mediate photothermal-derived cuproptosis and immune activation. ACS Nano 18, 23941\u201323957 (2024).","journal-title":"ACS Nano"},{"key":"2192_CR475","doi-asserted-by":"publisher","first-page":"25185","DOI":"10.1021\/acsnano.3c08267","volume":"17","author":"Z Su","year":"2023","unstructured":"Su, Z. et al. Nanostrategy of targeting at embryonic trophoblast cells using CuO nanoparticles for female contraception. ACS Nano 17, 25185\u201325204 (2023).","journal-title":"ACS Nano"},{"key":"2192_CR476","doi-asserted-by":"publisher","first-page":"10495","DOI":"10.1021\/acsnano.3c11818","volume":"18","author":"W Tang","year":"2024","unstructured":"Tang, W. et al. Bioactive layered double hydroxides for synergistic sonodynamic\/cuproptosis anticancer therapy with elicitation of the immune response. ACS Nano 18, 10495\u201310508 (2024).","journal-title":"ACS Nano"},{"key":"2192_CR477","doi-asserted-by":"publisher","first-page":"17852","DOI":"10.1021\/acsnano.4c04022","volume":"18","author":"C Zhao","year":"2024","unstructured":"Zhao, C., Tang, X., Chen, X. & Jiang, Z. Multifaceted carbonized metal-organic frameworks synergize with immune checkpoint inhibitors for precision and augmented cuproptosis cancer therapy. ACS Nano 18, 17852\u201317868 (2024).","journal-title":"ACS Nano"},{"key":"2192_CR478","doi-asserted-by":"publisher","first-page":"30033","DOI":"10.1021\/jacs.4c06338","volume":"146","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Polyvalent aptamer nanodrug conjugates enable efficient tumor cuproptosis therapy through copper overload and glutathione depletion. J. Am. Chem. Soc. 146, 30033\u201330045 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2192_CR479","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108218","volume":"26","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer. iScience 26, 108218 (2023).","journal-title":"iScience"},{"key":"2192_CR480","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48227-y","volume":"15","author":"N Chen","year":"2024","unstructured":"Chen, N. et al. Sleep fragmentation exacerbates myocardial ischemia\u2012reperfusion injury by promoting copper overload in cardiomyocytes. Nat. Commun. 15, 3834 (2024).","journal-title":"Nat. Commun."},{"key":"2192_CR481","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","volume":"17","author":"S Ning","year":"2023","unstructured":"Ning, S. et al. Type-I AIE photosensitizer-loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge. ACS Nano 17, 10206\u201310217 (2023).","journal-title":"ACS Nano"},{"key":"2192_CR482","doi-asserted-by":"crossref","unstructured":"Huo, S. et al. ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int. J. Mol. Sci. 24 (2023).","DOI":"10.3390\/ijms24021667"},{"key":"2192_CR483","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zhang, L. & Zhou, F. Cuproptosis: a new form of programmed cell death. Cell Mol. Immunol. 19, 867\u2013868 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"2192_CR484","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed. Pharmacother. 163, 114830 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2192_CR485","doi-asserted-by":"publisher","first-page":"340993","DOI":"10.1016\/j.aca.2023.340993","volume":"1251","author":"Y Lu","year":"2023","unstructured":"Lu, Y., Wei, X., Chen, M. & Wang, J. Non-ceruloplasmin-bound copper and copper speciation in serum with extraction using functionalized dendritic silica spheres followed by ICP-MS detection. Anal. Chim. Acta 1251, 340993 (2023).","journal-title":"Anal. Chim. Acta"},{"key":"2192_CR486","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.aca.2019.06.047","volume":"1079","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Determination of interactions between antibody biotherapeutics and copper by size exclusion chromatography (SEC) coupled with inductively coupled plasma mass spectrometry (ICP\/MS). Anal. Chim. Acta 1079, 252\u2013259 (2019).","journal-title":"Anal. Chim. Acta"},{"key":"2192_CR487","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1007\/s00216-021-03769-8","volume":"414","author":"C Duroux","year":"2022","unstructured":"Duroux, C. & Hag\u00e8ge, A. Interactions between copper (II) and \u03b2-amyloid peptide using capillary electrophoresis-ICP-MS: Kd measurements at the nanogram scale. Anal. Bioanal. Chem. 414, 5347\u20135355 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"2192_CR488","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1002\/jsfa.10558","volume":"100","author":"M Hayder","year":"2020","unstructured":"Hayder, M. et al. Analysis of cerium oxide and copper oxide nanoparticles bioaccessibility from radish using SP-ICP-MS. J. Sci. Food Agric. 100, 4950\u20134958 (2020).","journal-title":"J. Sci. Food Agric."},{"key":"2192_CR489","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102910","volume":"67","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Associations of essential trace elements with epigenetic aging indicators and the potential mediating role of inflammation. Redox Biol. 67, 102910 (2023).","journal-title":"Redox Biol."},{"key":"2192_CR490","first-page":"265","volume":"22","author":"G Fernandes","year":"2020","unstructured":"Fernandes, G., Renn\u00e9, W. G., Visser, M. B. & Sabatini, C. Esterase inhibition and copper release from copper iodide dental adhesives\u2014an in vitro study. J. Adhes. Dent. 22, 265\u2013274 (2020).","journal-title":"J. Adhes. Dent."},{"key":"2192_CR491","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304522","volume":"13","author":"J Deng","year":"2024","unstructured":"Deng, J. et al. Mitochondrial-targeted copper delivery for cuproptosis-based synergistic cancer therapy. Adv. Health. Mater. 13, e2304522 (2024).","journal-title":"Adv. Health. Mater."},{"key":"2192_CR492","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nchembio.1913","volume":"11","author":"CJ Chang","year":"2015","unstructured":"Chang, C. J. Searching for harmony in transition-metal signaling. Nat. Chem. Biol. 11, 744\u2013747 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"2192_CR493","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1039\/D1SC06156A","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Identification of two-dimensional copper signatures in human blood for bladder cancer with machine learning. Chem. Sci. 13, 1648\u20131656 (2022).","journal-title":"Chem. Sci."},{"key":"2192_CR494","doi-asserted-by":"publisher","first-page":"e202213644","DOI":"10.1002\/anie.202213644","volume":"62","author":"VN Pham","year":"2023","unstructured":"Pham, V. N. & Chang, C. J. Metalloallostery and transition metal signaling: bioinorganic copper chemistry beyond active sites. Angew. Chem. Int. Ed. Engl. 62, e202213644 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2192_CR495","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16513-0","volume":"11","author":"K Hu","year":"2020","unstructured":"Hu, K. et al. Marriage of black phosphorus and Cu(2+) as effective photothermal agents for PET-guided combination cancer therapy. Nat. Commun. 11, 2778 (2020).","journal-title":"Nat. Commun."},{"key":"2192_CR496","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1021\/ja900884j","volume":"131","author":"EL Que","year":"2009","unstructured":"Que, E. L. et al. Copper-responsive magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 131, 8527\u20138536 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"2192_CR497","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2967\/jnumed.118.212803","volume":"59","author":"JJ Bartnicka","year":"2018","unstructured":"Bartnicka, J. J. & Blower, P. J. Insights into trace metal metabolism in health and disease from PET: \u201cPET metallomics\u201d. J. Nucl. Med. 59, 1355\u20131359 (2018).","journal-title":"J. Nucl. Med."},{"key":"2192_CR498","first-page":"159","volume":"31","author":"P Panichelli","year":"2016","unstructured":"Panichelli, P. et al. Imaging of brain tumors with copper-64 chloride: early experience and results. Cancer Biother. Radiopharm. 31, 159\u2013167 (2016).","journal-title":"Cancer Biother. Radiopharm."},{"key":"2192_CR499","doi-asserted-by":"crossref","unstructured":"Piccardo, A. et al. (64)CuCl(2) PET\/CT in prostate cancer relapse. J. Nucl. Med. 59, 444\u2013451 (2018).","DOI":"10.2967\/jnumed.117.195628"},{"key":"2192_CR500","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","volume":"375","author":"MA Kahlson","year":"2022","unstructured":"Kahlson, M. A. & Dixon, S. J. Copper-induced cell death. Science 375, 1231\u20131232 (2022).","journal-title":"Science"},{"key":"2192_CR501","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118444","volume":"333","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Qiju Dihuang Pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract. J. Ethnopharmacol. 333, 118444 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"2192_CR502","doi-asserted-by":"publisher","first-page":"112912","DOI":"10.1016\/j.intimp.2024.112912","volume":"140","author":"D Wang","year":"2024","unstructured":"Wang, D., Deng, X., Li, S. & Sana, S. Impact of SARS-CoV-2 infection on immune cell cuproptosis in patients with lung adenocarcinoma via glutamine regulation. Int. Immunopharmacol. 140, 112912 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2192_CR503","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","volume":"17","author":"F Chen","year":"2024","unstructured":"Chen, F., Kang, R., Tang, D. & Liu, J. Ferroptosis: principles and significance in health and disease. J. Hematol. Oncol. 17, 41 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"2192_CR504","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"2192_CR505","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.986214","volume":"13","author":"JY Liu","year":"2022","unstructured":"Liu, J. Y. et al. The role of cuproptosis-related gene in the classification and prognosis of melanoma. Front. Immunol. 13, 986214 (2022).","journal-title":"Front. Immunol."},{"key":"2192_CR506","doi-asserted-by":"publisher","first-page":"963220","DOI":"10.3389\/fendo.2022.963220","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Front Endocrinol. 13, 963220 (2022).","journal-title":"Front Endocrinol."},{"key":"2192_CR507","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45076-5","volume":"13","author":"XM Ran","year":"2023","unstructured":"Ran, X. M. et al. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation. Sci. Rep. 13, 19474 (2023).","journal-title":"Sci. Rep."},{"key":"2192_CR508","doi-asserted-by":"publisher","first-page":"19507","DOI":"10.1073\/pnas.1318431110","volume":"110","author":"S Ishida","year":"2013","unstructured":"Ishida, S. et al. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc. Natl. Acad. Sci. USA 110, 19507\u201319512 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2192_CR509","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","volume":"17","author":"S Ishida","year":"2010","unstructured":"Ishida, S., McCormick, F., Smith-McCune, K. & Hanahan, D. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell 17, 574\u2013583 (2010).","journal-title":"Cancer Cell"},{"key":"2192_CR510","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401396","volume":"11","author":"X Gao","year":"2024","unstructured":"Gao, X. et al. Enzalutamide sensitizes castration-resistant prostate cancer to copper-mediated cell death. Adv. Sci. 11, e2401396 (2024).","journal-title":"Adv. Sci."},{"key":"2192_CR511","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10637-012-9864-0","volume":"31","author":"BJ Schneider","year":"2013","unstructured":"Schneider, B. J. et al. Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer. Investig. New Drugs 31, 435\u2013442 (2013).","journal-title":"Investig. New Drugs"},{"key":"2192_CR512","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","volume":"23","author":"N Chan","year":"2017","unstructured":"Chan, N. et al. Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases. Clin. Cancer Res. 23, 666\u2013676 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2192_CR513","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1172\/JCI71714","volume":"124","author":"A Glasauer","year":"2014","unstructured":"Glasauer, A. et al. Targeting SOD1 reduces experimental non\u2013small-cell lung cancer. J. Clin. Investig. 124, 117\u2013128 (2014).","journal-title":"J. Clin. Investig."},{"key":"2192_CR514","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2013.02.003","volume":"60","author":"K Lee","year":"2013","unstructured":"Lee, K. et al. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies. Free Radic. Biol. Med. 60, 157\u2013167 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR515","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3892\/ijo.2014.2396","volume":"45","author":"K Lee","year":"2014","unstructured":"Lee, K. et al. The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma. Int. J. Oncol. 45, 439\u2013447 (2014).","journal-title":"Int. J. Oncol."},{"key":"2192_CR516","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1227\/00006123-199508000-00014","volume":"37","author":"D Yoshida","year":"1995","unstructured":"Yoshida, D., Ikeda, Y. & Nakazawa, S. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model. Neurosurgery 37, 287\u2013292 (1995). discussion 292-283.","journal-title":"Neurosurgery"},{"key":"2192_CR517","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.freeradbiomed.2007.07.003","volume":"43","author":"A Gupte","year":"2007","unstructured":"Gupte, A. & Mumper, R. J. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells. Free Radic. Biol. Med. 43, 1271\u20131278 (2007).","journal-title":"Free Radic. Biol. Med."},{"key":"2192_CR518","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073684","volume":"8","author":"A Crowe","year":"2013","unstructured":"Crowe, A. et al. Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration. PLoS One 8, e73684 (2013).","journal-title":"PLoS One"},{"key":"2192_CR519","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-009-0470-6","volume":"121","author":"Y Qu","year":"2010","unstructured":"Qu, Y. et al. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Res. Treat. 121, 311\u2013321 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"2192_CR520","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18655","volume":"9","author":"G Chen","year":"2023","unstructured":"Chen, G. et al. FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis. Heliyon 9, e18655 (2023).","journal-title":"Heliyon"},{"key":"2192_CR521","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1038\/s41388-022-02364-0","volume":"41","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Copper ionophore elesclomol selectively targets GNAQ\/11-mutant uveal melanoma. Oncogene 41, 3539\u20133553 (2022).","journal-title":"Oncogene"},{"key":"2192_CR522","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300980R","volume":"37","author":"H Wen","year":"2023","unstructured":"Wen, H. et al. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT\/mTOR pathway in prostate cancer. FASEB J. 37, e23145 (2023).","journal-title":"FASEB J."},{"key":"2192_CR523","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.734853","volume":"11","author":"X Zheng","year":"2021","unstructured":"Zheng, X. et al. Disulfiram improves the Anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer. Front Oncol. 11, 734853 (2021).","journal-title":"Front Oncol."},{"key":"2192_CR524","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41418-023-01167-4","volume":"30","author":"DC Kanellis","year":"2023","unstructured":"Kanellis, D. C. et al. Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death Differ. 30, 1666\u20131678 (2023).","journal-title":"Cell Death Differ."},{"key":"2192_CR525","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.05.026","volume":"379","author":"JY Kim","year":"2016","unstructured":"Kim, J. Y. et al. Disulfiram targets cancer stem-like properties and the HER2\/Akt signaling pathway in HER2-positive breast cancer. Cancer Lett. 379, 39\u201348 (2016).","journal-title":"Cancer Lett."},{"key":"2192_CR526","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09574-5","volume":"22","author":"HZ Cao","year":"2022","unstructured":"Cao, H. Z., Yang, W. T. & Zheng, P. S. Cytotoxic effect of disulfiram\/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells. BMC Cancer 22, 521 (2022).","journal-title":"BMC Cancer"},{"key":"2192_CR527","doi-asserted-by":"crossref","unstructured":"Xie, J. et al. Disulfiram\/Cu kills and sensitizes BRAF-mutant thyroid cancer cells to BRAF kinase inhibitor by ROS-dependently relieving feedback activation of MAPK\/ERK and PI3K\/AKT pathways. Int. J. Mol. Sci. 24, (2023).","DOI":"10.3390\/ijms24043418"},{"key":"2192_CR528","doi-asserted-by":"crossref","unstructured":"Ni, Y. L. et al. Disulfiram\/copper suppresses cancer stem cell activity in differentiated thyroid cancer cells by inhibiting BMI1 expression. Int. J. Mol. Sci. 23, (2022).","DOI":"10.3390\/ijms232113276"},{"key":"2192_CR529","first-page":"2055","volume":"13","author":"S Huang","year":"2023","unstructured":"Huang, S. et al. Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression. Am. J. Cancer Res. 13, 2055\u20132065 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"2192_CR530","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115642","volume":"426","author":"E Read","year":"2021","unstructured":"Read, E. et al. The interaction of disulfiram and H(2)S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth. Toxicol. Appl. Pharm. 426, 115642 (2021).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2192_CR531","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000353915","volume":"59","author":"J Navr\u00e1tilov\u00e1","year":"2013","unstructured":"Navr\u00e1tilov\u00e1, J., Hankeov\u00e1, T., Bene\u0161, P. & \u0160marda, J. Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram\/Cu2+ complex to breast and colon cancer cells. Chemotherapy 59, 112\u2013120 (2013).","journal-title":"Chemotherapy"},{"key":"2192_CR532","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11060-019-03125-y","volume":"142","author":"J Huang","year":"2019","unstructured":"Huang, J. et al. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma. J. Neurooncol. 142, 537\u2013544 (2019).","journal-title":"J. Neurooncol."},{"key":"2192_CR533","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11060-016-2104-2","volume":"128","author":"J Huang","year":"2016","unstructured":"Huang, J. et al. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. J. Neurooncol. 128, 259\u2013266 (2016).","journal-title":"J. Neurooncol."},{"key":"2192_CR534","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/pros.24329","volume":"82","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer. Prostate 82, 858\u2013866 (2022).","journal-title":"Prostate"},{"key":"2192_CR535","first-page":"2087","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu, H., Lou, J. R. & Ding, W. Q. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells. Anticancer Res. 30, 2087\u20132092 (2010).","journal-title":"Anticancer Res."},{"key":"2192_CR536","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-06-3546","volume":"67","author":"D Chen","year":"2007","unstructured":"Chen, D. et al. Clioquinol, a therapeutic agent for Alzheimer\u2019s disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res. 67, 1636\u20131644 (2007).","journal-title":"Cancer Res."},{"key":"2192_CR537","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4264-2","volume":"18","author":"S Lu","year":"2018","unstructured":"Lu, S. et al. Radiosensitization of clioquinol and zinc in human cancer cell lines. BMC Cancer 18, 448 (2018).","journal-title":"BMC Cancer"},{"key":"2192_CR538","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.xphs.2020.04.010","volume":"110","author":"C Yap","year":"2021","unstructured":"Yap, C., Short, J. L. & Nicolazzo, J. A. A combination of clioquinol, zinc and copper increases the abundance and function of breast cancer resistance protein in human brain microvascular endothelial cells. J. Pharm. Sci. 110, 338\u2013346 (2021).","journal-title":"J. Pharm. Sci."},{"key":"2192_CR539","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bcp.2009.02.002","volume":"77","author":"ER Tuller","year":"2009","unstructured":"Tuller, E. R. et al. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem. Pharm. 77, 1480\u20131486 (2009).","journal-title":"Biochem. Pharm."},{"key":"2192_CR540","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1124\/jpet.107.130377","volume":"324","author":"T Du","year":"2008","unstructured":"Du, T. et al. Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages. J. Pharm. Exp. Ther. 324, 360\u2013367 (2008).","journal-title":"J. Pharm. Exp. Ther."},{"key":"2192_CR541","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.clml.2012.05.005","volume":"12","author":"AD Schimmer","year":"2012","unstructured":"Schimmer, A. D. et al. A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. Clin. Lymphoma Myeloma Leuk. 12, 330\u2013336 (2012).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"2192_CR542","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11274-022-03368-4","volume":"38","author":"JD Balthazar","year":"2022","unstructured":"Balthazar, J. D. et al. 8-Hydroxyquinoline a natural chelating agent from Streptomyces spp. inhibits A549 lung cancer cell lines via BCL2\/STAT3 regulating pathways. World J. Microbiol. Biotechnol. 38, 182 (2022).","journal-title":"World J. Microbiol. Biotechnol."},{"key":"2192_CR543","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/gcc.22476","volume":"56","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276). Genes Chromosomes Cancer 56, 719\u2013729 (2017).","journal-title":"Genes Chromosomes Cancer"},{"key":"2192_CR544","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/srep05240","volume":"4","author":"N Liu","year":"2014","unstructured":"Liu, N. et al. A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases. Sci. Rep. 4, 5240 (2014).","journal-title":"Sci. Rep."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02192-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:02:39Z","timestamp":1746730959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":544,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2192"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02192-0","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}